67 results on '"Angélique B. van 't Wout"'
Search Results
2. Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity
- Author
-
Xue-Song Zhang, Jackie Li, Kimberly A Krautkramer, Michelle Badri, Thomas Battaglia, Timothy C Borbet, Hyunwook Koh, Sandy Ng, Rachel A Sibley, Yuanyuan Li, Wimal Pathmasiri, Shawn Jindal, Robin R Shields-Cutler, Ben Hillmann, Gabriel A Al-Ghalith, Victoria E Ruiz, Alexandra Livanos, Angélique B van ‘t Wout, Nabeetha Nagalingam, Arlin B Rogers, Susan Jenkins Sumner, Dan Knights, John M Denu, Huilin Li, Kelly V Ruggles, Richard Bonneau, R Anthony Williamson, Marcus Rauch, and Martin J Blaser
- Subjects
microbiome ,autoimmune ,NOD mice ,animal models ,immune maturation ,gene expression ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
The early-life intestinal microbiota plays a key role in shaping host immune system development. We found that a single early-life antibiotic course (1PAT) accelerated type 1 diabetes (T1D) development in male NOD mice. The single course had deep and persistent effects on the intestinal microbiome, leading to altered cecal, hepatic, and serum metabolites. The exposure elicited sex-specific effects on chromatin states in the ileum and liver and perturbed ileal gene expression, altering normal maturational patterns. The global signature changes included specific genes controlling both innate and adaptive immunity. Microbiome analysis revealed four taxa each that potentially protect against or accelerate T1D onset, that were linked in a network model to specific differences in ileal gene expression. This simplified animal model reveals multiple potential pathways to understand pathogenesis by which early-life gut microbiome perturbations alter a global suite of intestinal responses, contributing to the accelerated and enhanced T1D development.
- Published
- 2018
- Full Text
- View/download PDF
3. Reconstructing the Dynamics of HIV Evolution within Hosts from Serial Deep Sequence Data.
- Author
-
Art F. Y. Poon, Luke C. Swenson, Evelien M. Bunnik, Diana Edo-Matas, Hanneke Schuitemaker, Angélique B. van 't Wout, and P. Richard Harrigan
- Published
- 2012
- Full Text
- View/download PDF
4. Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia.
- Author
-
Sebastiaan M Bol, Thijs Booiman, Daniëlle van Manen, Evelien M Bunnik, Ard I van Sighem, Margit Sieberer, Brigitte Boeser-Nunnink, Frank de Wolf, Hanneke Schuitemaker, Peter Portegies, Neeltje A Kootstra, and Angélique B van 't Wout
- Subjects
Medicine ,Science - Abstract
BACKGROUND: Infection with HIV-1 may result in severe cognitive and motor impairment, referred to as HIV-1-associated dementia (HAD). While its prevalence has dropped significantly in the era of combination antiretroviral therapy, milder neurocognitive disorders persist with a high prevalence. To identify additional therapeutic targets for treating HIV-associated neurocognitive disorders, several candidate gene polymorphisms have been evaluated, but few have been replicated across multiple studies. METHODS: We here tested 7 candidate gene polymorphisms for association with HAD in a case-control study consisting of 86 HAD cases and 246 non-HAD AIDS patients as controls. Since infected monocytes and macrophages are thought to play an important role in the infection of the brain, 5 recently identified single nucleotide polymorphisms (SNPs) affecting HIV-1 replication in macrophages in vitro were also tested. RESULTS: The CCR5 wt/Δ32 genotype was only associated with HAD in individuals who developed AIDS prior to 1991, in agreement with the observed fading effect of this genotype on viral load set point. A significant difference in genotype distribution among all cases and controls irrespective of year of AIDS diagnosis was found only for a SNP in candidate gene PREP1 (p = 1.2 × 10(-5)). Prep1 has recently been identified as a transcription factor preferentially binding the -2,518 G allele in the promoter of the gene encoding MCP-1, a protein with a well established role in the etiology of HAD. CONCLUSION: These results support previous findings suggesting an important role for MCP-1 in the onset of HIV-1-associated neurocognitive disorders.
- Published
- 2012
- Full Text
- View/download PDF
5. Development of reliable, valid and responsive scoring systems for endoscopy and histology in animal models for inflammatory bowel disease
- Author
-
Michael Vieth, Pim J. Koelink, Larry Stitt, Brian G. Feagan, Suzanne Duijst, Geert R. D'Haens, Angélique B van ‘t Wout, Raja Atreya, Johannan F. Brandse, Anje A. te Velde, Martin Koldijk, Gijs R. van den Brink, Manon E. Wildenberg, Barrett G. Levesque, AII - Inflammatory diseases, Gastroenterology and Hepatology, AGEM - Re-generation and cancer of the digestive system, AGEM - Digestive immunity, and Tytgat Institute for Liver and Intestinal Research
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Intraclass correlation ,Basic science ,Mice, SCID ,Severity of Illness Index ,Gastroenterology ,Spearman's rank correlation coefficient ,Inflammatory bowel disease ,Endoscopy, Gastrointestinal ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Severity of illness ,medicine ,Animals ,Colitis ,Observer Variation ,Mice, Inbred BALB C ,medicine.diagnostic_test ,Tumor Necrosis Factor-alpha ,business.industry ,Antibodies, Monoclonal ,Reproducibility of Results ,Histology ,Original Articles ,General Medicine ,medicine.disease ,experimental pathophysiology ,Endoscopy ,Disease Models, Animal ,Inter-rater reliability ,030104 developmental biology ,Female ,030211 gastroenterology & hepatology ,business - Abstract
Background and Aims Although several endoscopic and histopathologic indices are available for evaluating the severity of inflammation in mouse models of colitis, the reliability of these scoring instruments is unknown. Our aim was to evaluate the reliability of the individual items in the existing indices and develop new scoring systems by selection of the most reliable index items. Methods Two observers scored the histological slides [n = 224] and endoscopy videos [n = 201] from treated and untreated Interleukin[IL]-10 knock-out and T-cell transferred SCID mice. Intra-rater and inter-rater reliability for endoscopy and histology scores, and each individual item, were measured using intraclass correlation coefficients [ICCs]. The Mouse Colitis Histology Index [MCHI] and Mouse Colitis Endoscopy Index [MCEI] were developed using the most reliable items. Both were correlated to the colon density and to each other and were evaluated for their ability to detect changes in pathobiology. Results The intraclass correlation coefficients (ICCs) for inter-rater agreement (95% CIs) for the total histology and endoscopy scores were 0.90 [0.87–0.92] and 0.80 [0.76–0.84], respectively. The MCHI and MCEI were highly correlated with colon density, with a Spearman Rho = 0.81[0.75–0.85] and 0.73 [0.66–0.79], respectively, and with each other, Spearman Rho = 0.71 [0.63–0.77]. The MCHI and MCEI were able to distinguish between the experimental groups within the models, with pairwise differences between the treated and untreated groups being statistically significant [p < 0.001]. Conclusions These histological and endoscopic indices are valid and reliable measures of intestinal inflammation in mice, and they are responsive to treatment effects in pre-clinical studies.
- Published
- 2018
6. Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages.
- Author
-
Sebastiaan M Bol, Perry D Moerland, Sophie Limou, Yvonne van Remmerden, Cédric Coulonges, Daniëlle van Manen, Joshua T Herbeck, Jacques Fellay, Margit Sieberer, Jantine G Sietzema, Ruben van 't Slot, Jeremy Martinson, Jean-François Zagury, Hanneke Schuitemaker, and Angélique B van 't Wout
- Subjects
Medicine ,Science - Abstract
HIV-1 infected macrophages play an important role in rendering resting T cells permissive for infection, in spreading HIV-1 to T cells, and in the pathogenesis of AIDS dementia. During highly active anti-retroviral treatment (HAART), macrophages keep producing virus because tissue penetration of antiretrovirals is suboptimal and the efficacy of some is reduced. Thus, to cure HIV-1 infection with antiretrovirals we will also need to efficiently inhibit viral replication in macrophages. The majority of the current drugs block the action of viral enzymes, whereas there is an abundance of yet unidentified host factors that could be targeted. We here present results from a genome-wide association study identifying novel genetic polymorphisms that affect in vitro HIV-1 replication in macrophages.Monocyte-derived macrophages from 393 blood donors were infected with HIV-1 and viral replication was determined using Gag p24 antigen levels. Genomic DNA from individuals with macrophages that had relatively low (n = 96) or high (n = 96) p24 production was used for SNP genotyping with the Illumina 610 Quad beadchip. A total of 494,656 SNPs that passed quality control were tested for association with HIV-1 replication in macrophages, using linear regression. We found a strong association between in vitro HIV-1 replication in monocyte-derived macrophages and SNP rs12483205 in DYRK1A (p = 2.16 × 10(-5)). While the association was not genome-wide significant (p
- Published
- 2011
- Full Text
- View/download PDF
7. Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity
- Author
-
Victoria E. Ruiz, Nabeetha A. Nagalingam, Robin R. Shields-Cutler, Alexandra E. Livanos, Ben Hillmann, Gabriel A. Al-Ghalith, Jackie Li, Rachel A Sibley, Marcus Rauch, Kelly V. Ruggles, Xue-Song Zhang, Angélique B van ‘t Wout, Timothy C. Borbet, Huilin Li, Martin J. Blaser, Susan Sumner, John M. Denu, R. Anthony Williamson, Yuanyuan Li, Dan Knights, Hyunwook Koh, Michelle H. Badri, Kimberly A. Krautkramer, Richard Bonneau, Shawn Jindal, Arlin B. Rogers, Thomas Battaglia, Wimal Pathmasiri, and Sandy Ng
- Subjects
0301 basic medicine ,Mouse ,QH301-705.5 ,Science ,microbiome ,Inflammation ,Adaptive Immunity ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Pathogenesis ,Mice ,03 medical and health sciences ,Immunology and Inflammation ,Immune system ,Ileum ,Mice, Inbred NOD ,Gene expression ,medicine ,Animals ,Microbiome ,Biology (General) ,NOD mice ,Microbiology and Infectious Disease ,General Immunology and Microbiology ,Microbiota ,General Neuroscience ,autoimmune ,General Medicine ,Acquired immune system ,animal models ,Immunity, Innate ,immune maturation ,Anti-Bacterial Agents ,Gastrointestinal Microbiome ,3. Good health ,Chromatin ,Intestines ,Diabetes Mellitus, Type 1 ,030104 developmental biology ,Immunology ,gene expression ,Medicine ,Female ,medicine.symptom ,Research Article - Abstract
The early-life intestinal microbiota plays a key role in shaping host immune system development. We found that a single early-life antibiotic course (1PAT) accelerated type 1 diabetes (T1D) development in male NOD mice. The single course had deep and persistent effects on the intestinal microbiome, leading to altered cecal, hepatic, and serum metabolites. The exposure elicited sex-specific effects on chromatin states in the ileum and liver and perturbed ileal gene expression, altering normal maturational patterns. The global signature changes included specific genes controlling both innate and adaptive immunity. Microbiome analysis revealed four taxa each that potentially protect against or accelerate T1D onset, that were linked in a network model to specific differences in ileal gene expression. This simplified animal model reveals multiple potential pathways to understand pathogenesis by which early-life gut microbiome perturbations alter a global suite of intestinal responses, contributing to the accelerated and enhanced T1D development., eLife digest The human body contains many microbes that play important roles in our health. These microbes begin to live in the intestines, skin, and mouth shortly after birth. They form complex communities called the microbiome, which changes as babies develop. The microbiome works with organs to maintain human health. For example, the lower intestinal tract is home to the most numerous and active microbes in the body. The intestines provide microbes with food and a welcoming environment, and the microbes make products the body needs, influence immune system development, and help maintain a balance of beneficial microbes. Use of antibiotics to treat infections, particularly early in life, disrupts intestinal microbe communities. Recent studies show that such microbiome disturbances may affect how the immune system develops and the rate at which type 1 diabetes develops. Type 1 diabetes is an autoimmune disease in which the immune system destroys cells in the pancreas that produce insulin. Scientists would like to learn more about how use of antibiotics in early life may contribute to the development of this disease. Now, Zhang et al. show that a single course of antibiotics administered early in life accelerates the development of type 1 diabetes in mice prone to develop the disease. In the experiments, a strain of laboratory mice that spontaneously develops type 1 diabetes were either given a single course of antibiotics, three courses of antibiotics, or no antibiotics in their first weeks of life. After one single course, the gut microbiome was different in mice treated with antibiotics compared with mice who were never exposed. The antibiotics also changed the molecules produced by these microbes. These alterations in the microbiome turned on or off certain genes in the intestine, affecting the development of the immune system. Zhang et al. identified some microbes that appear to protect against type 1 diabetes and others that seem to speed it up and how they do so. Antibiotic use in children is very common, so finding ways to reduce its potentially harmful effects on development are critical. The experiments provide one way to study how antibiotics may contribute to autoimmune disease. It also may allow scientists to test ways to reverse harmful change.
- Published
- 2018
8. Author response: Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity
- Author
-
Yuanyuan Li, Michelle H. Badri, Alexandra E. Livanos, Thomas Battaglia, Nabeetha A. Nagalingam, Gabriel A. Al-Ghalith, Richard Bonneau, Ben Hillmann, Rachel A Sibley, Xue-Song Zhang, Kelly V. Ruggles, Susan Sumner, Victoria E. Ruiz, Kimberly A. Krautkramer, Shawn Jindal, R. Anthony Williamson, Robin R. Shields-Cutler, Wimal Pathmasiri, Martin J. Blaser, Sandy Ng, Timothy C. Borbet, Jackie Li, Marcus Rauch, John M. Denu, Hyunwook Koh, Huilin Li, Angélique B van ‘t Wout, Dan Knights, and Arlin B. Rogers
- Subjects
0301 basic medicine ,Type 1 diabetes ,medicine.drug_class ,Intestinal immunity ,Antibiotics ,030209 endocrinology & metabolism ,Acceleration (differential geometry) ,Biology ,medicine.disease ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Immunology ,medicine - Published
- 2018
9. Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies
- Author
-
Angélique B. van ‘t Wout, Jason S. McLellan, R. Anthony Williamson, Elissa Keogh, Tina Ritschel, Harrison G. Jones, Just P. J. Brakenhoff, Dirk Roymans, Ellen Lanckacker, Gabriel Pascual, Jehangir Wadia, Polina Furmanova-Hollenstein, Johannes P. M. Langedijk, and Morgan S.A. Gilman
- Subjects
0301 basic medicine ,Male ,Pulmonology ,Protein Conformation ,Physiology ,viruses ,Respiratory System ,Glycobiology ,Antibodies, Viral ,Crystallography, X-Ray ,Biochemistry ,Epitope ,Epithelium ,Epitopes ,Protein structure ,Animal Cells ,Immune Physiology ,CX3CR1 ,Medicine and Health Sciences ,Public and Occupational Health ,Enzyme-Linked Immunoassays ,lcsh:QH301-705.5 ,Cells, Cultured ,chemistry.chemical_classification ,Immune System Proteins ,Crystallography ,biology ,Physics ,virus diseases ,respiratory system ,Condensed Matter Physics ,3. Good health ,Physical Sciences ,Crystal Structure ,Antibody ,Cellular Types ,Anatomy ,Research Article ,lcsh:Immunologic diseases. Allergy ,030106 microbiology ,Immunology ,Bronchi ,Respiratory Syncytial Virus Infections ,Research and Analysis Methods ,Microbiology ,Viral Attachment ,Virus ,Antibodies ,03 medical and health sciences ,Immune system ,Virology ,Genetics ,Respiratory Syncytial Virus Vaccines ,Animals ,Humans ,Solid State Physics ,Sigmodontinae ,CX3CL1 ,Immunoassays ,Molecular Biology ,Glycoproteins ,Virus Glycoproteins ,Chemokine CX3CL1 ,Prophylaxis ,Biology and Life Sciences ,Proteins ,Epithelial Cells ,Cell Biology ,Antibodies, Neutralizing ,Rats ,030104 developmental biology ,Biological Tissue ,chemistry ,lcsh:Biology (General) ,Respiratory Syncytial Virus, Human ,Respiratory Infections ,biology.protein ,Immunologic Techniques ,Parasitology ,Preventive Medicine ,Glycoprotein ,lcsh:RC581-607 ,Viral Fusion Proteins ,Viral Transmission and Infection - Abstract
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in infants and the elderly, and yet there remains no effective treatment or vaccine. The surface of the virion is decorated with the fusion glycoprotein (RSV F) and the attachment glycoprotein (RSV G), which binds to CX3CR1 on human airway epithelial cells to mediate viral attachment and subsequent infection. RSV G is a major target of the humoral immune response, and antibodies that target the central conserved region of G have been shown to neutralize both subtypes of RSV and to protect against severe RSV disease in animal models. However, the molecular underpinnings for antibody recognition of this region have remained unknown. Therefore, we isolated two human antibodies directed against the central conserved region of RSV G and demonstrated that they neutralize RSV infection of human bronchial epithelial cell cultures in the absence of complement. Moreover, the antibodies protected cotton rats from severe RSV disease. Both antibodies bound with high affinity to a secreted form of RSV G as well as to a peptide corresponding to the unglycosylated central conserved region. High-resolution crystal structures of each antibody in complex with the G peptide revealed two distinct conformational epitopes that require proper folding of the cystine noose located in the C-terminal part of the central conserved region. Comparison of these structures with the structure of fractalkine (CX3CL1) alone or in complex with a viral homolog of CX3CR1 (US28) suggests that RSV G would bind to CX3CR1 in a mode that is distinct from that of fractalkine. Collectively, these results build on recent studies demonstrating the importance of RSV G in antibody-mediated protection from severe RSV disease, and the structural information presented here should guide the development of new vaccines and antibody-based therapies for RSV., Author summary Respiratory syncytial virus (RSV) is a common cause of bronchiolitis and pneumonia, and is a leading cause of infant deaths globally due to infectious disease. Despite decades of research, there is still no vaccine or widespread treatment for RSV. In this study, we isolated two antibodies that bind to the central conserved region of the viral attachment glycoprotein, RSV G. The antibodies effectively neutralize both subtypes of RSV and protect RSV-challenged animals from severe disease. We also determined high-resolution crystal structures of each antibody in complex with the central conserved region of RSV G to gain a better understanding of how these antibodies bind to RSV G and how they neutralize the virus. Because RSV G is a small folded domain bounded by unstructured mucin-like domains, structural elucidation of the central conserved region provides atomic-level information for the complete folded portion of RSV G. The results presented here will help develop effective antibodies for passive prophylaxis as well as guide efforts to design vaccines that elicit broadly neutralizing antibodies against RSV G.
- Published
- 2018
10. Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intra-host evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models
- Author
-
Hanneke Schuitemaker, Jennifer Tom, Agnes E. van den Blink, Diana Edo-Matas, Cèlia Serna-Bolea, Philippe Lemey, Marc A. Suchard, Angélique B. van 't Wout, Department of Experimental Immunology, Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA)-University of Amsterdam [Amsterdam] (UvA), Department of Microbiology and Immunology, Rega Institute, K.U. Leuven, Department of Biostatistics, University of California [Los Angeles] (UCLA), University of California-University of California, Universtitat de Barcelona, Barcelona Centre for International Health Research, Departments of Biomathematics and Human Genetics, Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
Male ,Heterozygote ,Genotype ,Receptors, CCR5 ,HIV Infections ,Sequence alignment ,HIV Envelope Protein gp120 ,Biology ,Evolution, Molecular ,03 medical and health sciences ,Phylogenetics ,Genetics ,Humans ,Evolutionary dynamics ,Molecular Biology ,Research Articles ,Phylogeny ,Ecology, Evolution, Behavior and Systematics ,Selection (genetic algorithm) ,030304 developmental biology ,Acquired Immunodeficiency Syndrome ,0303 health sciences ,Polymorphism, Genetic ,Models, Genetic ,Phylogenetic tree ,030306 microbiology ,Life Sciences ,Bayes Theorem ,Sequence Analysis, DNA ,CD4 Lymphocyte Count ,3. Good health ,Fixation (population genetics) ,Viral evolution ,Host-Pathogen Interactions ,Disease Progression ,HIV-1 ,Sequence Alignment ,Gene Deletion - Abstract
The interplay between C-C chemokine receptor type 5 (CCR5) host genetic background, disease progression, and intrahost HIV-1 evolutionary dynamics remains unclear because differences in viral evolution between hosts limit the ability to draw conclusions across hosts stratified into clinically relevant populations. Similar inference problems are proliferating across many measurably evolving pathogens for which intrahost sequence samples are readily available. To this end, we propose novel hierarchical phylogenetic models (HPMs) that incorporate fixed effects to test for differences in dynamics across host populations in a formal statistical framework employing stochastic search variable selection and model averaging. To clarify the role of CCR5 host genetic background and disease progression on viral evolutionary patterns, we obtain gp120 envelope sequences from clonal HIV-1 variants isolated at multiple time points in the course of infection from populations of HIV-1-infected individuals who only harbored CCR5-using HIV-1 variants at all time points. Presence or absence of a CCR5 wt/delta 32 genotype and progressive or long-term nonprogressive course of infection stratify the clinical populations in a two-way design. As compared with the standard approach of analyzing sequences from each patient independently, the HPM provides more efficient estimation of evolutionary parameters such as nucleotide substitution rates and d(N)/d(S) rate ratios, as shown by significant shrinkage of the estimator variance. The fixed effects also correct for nonindependence of data between populations and results in even further shrinkage of individual patient estimates. Model selection suggests an association between nucleotide substitution rate and disease progression, but a role for CCR5 genotype remains elusive. Given the absence of clear d(N)/d(S) differences between patient groups, delayed onset of AIDS symptoms appears to be solely associated with lower viral replication rates rather than with differences in selection on amino acid fixation
- Published
- 2011
- Full Text
- View/download PDF
11. Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control
- Author
-
Jan M. Prins, Frank de Wolf, Luuk Gras, Radjin Steingrover, Agnes M. Harskamp, Irma Maurer, Marga M. Mangas Ruiz, Angélique B. van 't Wout, Brigitte Boeser-Nunnink, Ard van Sighem, Daniëlle van Manen, Hanneke Schuitemaker, Other departments, Amsterdam institute for Infection and Immunity, Experimental Immunology, and Infectious diseases
- Subjects
Male ,RNA, Untranslated ,Time Factors ,Receptors, CCR5 ,Immunology ,HLA-C Antigens ,Biology ,Polymorphism, Single Nucleotide ,Loss of heterozygosity ,Cohort Studies ,Major Histocompatibility Complex ,Polymorphism (computer science) ,Genotype ,HIV Seropositivity ,Immunology and Allergy ,Humans ,Allele ,Gene ,Netherlands ,Ecology ,HCP5 ,Viral Load ,Virology ,Infectious Diseases ,Genetic marker ,Disease Progression ,HIV-1 ,Female ,RNA, Long Noncoding ,Viral load - Abstract
Objective: Heterozygosity for a 32 base pair deletion in the CCR5 gene (CCR5wt/Δ32) and the minor alleles of a single-nucleotide polymorphism in the HCP5 gene (rs2395029) and in the HLA-C gene region (−35HLA-C; rs9264942) has been associated with a lower viral load set point. Recent studies have shown that over calendar time, viral load set point has significantly increased at a population level. Here we studied whether this increase coincides with a fading impact of above-mentioned host genetic markers on HIV-1 control. Methods: We compared the association between viral load set point and HCP5 rs2395029, −35HLA-C rs9264942, and the CCR5wt/Δ32 genotype in HIV-1-infected individuals in the Netherlands who had seroconverted between 1982 and 2002 (pre-2003 seroconverters, n = 459) or between 2003 and 2009 (post-2003 seroconverters, n = 231). Results: Viral load set point in post-2003 seroconverters was significantly higher than in pre-2003 seroconverters (P = 4.5 × 10−5). The minor alleles for HCP5 rs2395029, −35HLA-C rs9264942 and CCR5wt/Δ32 had a similar prevalence in both groups and were all individually associated with a significantly lower viral load set point in pre-2003 seroconverters. In post-2003 seroconverters, this association was no longer observed for HCP5 rs2395029 and CCR5wt/Δ32. The association between viral load set point and HCP5 rs2395029 had significantly changed over time, whereas the change in impact of the CCR5wt/Δ32 genotype over calendar time was not independent from the other markers under study. Conclusion: The increased viral load set point at a population level coincides with a lost impact of certain host genetic factors on HIV-1 control.
- Published
- 2011
12. Multiple‐Cohort Genetic Association Study Reveals CXCR6 as a New Chemokine Receptor Involved in Long‐Term Nonprogression to AIDS
- Author
-
Susan Buchbinder, Olivier Delaneau, Ivo Gut, Yves Levy, Matthieu Montes, Cheryl A. Winkler, Ping An, Gora Diop, James I. Mullins, Christine Rouzioux, Hanneke Schuitemaker, Philippe Froguel, Jérôme Estaquier, Jean-François Delfraissy, James J. Goedert, Amu Therwath, Jean-Daniel Lelièvre, Christian Dina, Sigrid Le Clerc, Angélique B. van 't Wout, Lieng Taing, Serge Hercberg, Sophie Limou, François Schächter, John P. Phair, Jean-François Zagury, Cédric Coulonges, Joshua T. Herbeck, Geoffrey S. Gottlieb, Sharyne M. Donfield, Daniëlle van Manen, Other departments, Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
Male ,Virus genetics ,Single-nucleotide polymorphism ,Genome-wide association study ,Biology ,HIV Long-Term Survivors ,Cohort Studies ,Major Articles and Brief Reports ,Humans ,Immunology and Allergy ,Genetic Association Studies ,Receptors, CXCR6 ,Genetic association ,Genetics ,Acquired Immunodeficiency Syndrome ,Polymorphism, Genetic ,HCP5 ,Odds ratio ,Immunity, Innate ,Infectious Diseases ,Immunology ,HIV-1 ,Receptors, Virus ,Receptors, Chemokine ,Viral disease ,Viral load - Abstract
a Background. The compilation of previous genomewide association studies of AIDS shows a major polymor- phism in the HCP5 gene associated with both control of the viral load and long-term nonprogression (LTNP) to AIDS. Methods. To look for genetic variants that affect LTNP without necessary control of the viral load, we reanalyzed the genomewide data of the unique LTNP Genomics of Resistance to Immunodeficiency Virus (GRIV) cohort by excluding "elite controller" patients, who were controlling the viral load at very low levels (!100 copies/mL). Results. The rs2234358 polymorphism in the CXCR6 gene was the strongest signal ( ; odds ratio, 7 P p 2.5 10 1.85) obtained for the genomewide association study comparing the 186 GRIV LTNPs who were not elite controllers with 697 uninfected control subjects. This association was replicated in 3 additional independent European studies, reaching genomewide significance of . This association with LTNP is independent of the 10 P p 9.7 10 combined CCR2-CCR5 locus and the HCP5 polymorphisms. Conclusions. The statistical significance, the replication, and the magnitude of the association demonstrate that CXCR6 is likely involved in the molecular etiology of AIDS and, in particular, in LTNP, emphasizing the power of extreme-phenotype cohorts. CXCR6 is a chemokine receptor that is known as a minor coreceptor in human immunodeficiency virus type 1 infection but could participate in disease progression through its role as a mediator of inflammation.
- Published
- 2010
13. Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection
- Author
-
Marit J. van Gils, Emma J. Bowles, Brigitte Boeser-Nunnink, Diana Edo-Matas, Hanneke Schuitemaker, Marjon Navis, Guillaume Stewart-Jones, Angélique B. van 't Wout, Neeltje A. Kootstra, Andrea Rachinger, Amsterdam institute for Infection and Immunity, Medical Microbiology and Infection Prevention, and Experimental Immunology
- Subjects
Receptors, CXCR4 ,Receptors, CCR5 ,Population ,HIV Infections ,Viral quasispecies ,Biology ,Virus Replication ,Peripheral blood mononuclear cell ,Virus ,HIV Envelope Protein gp160 ,03 medical and health sciences ,chemistry.chemical_compound ,Plasma ,Proviruses ,Virology ,Humans ,Cloning, Molecular ,education ,030304 developmental biology ,CXCR4 ,0303 health sciences ,education.field_of_study ,Clonal HIV-1 variants ,030302 biochemistry & molecular biology ,PBMC ,RNA ,Genetic Variation ,virus diseases ,Viral Load ,3. Good health ,CD4 Lymphocyte Count ,chemistry ,Viral replication ,Immunology ,DNA, Viral ,Leukocytes, Mononuclear ,HIV-1 ,RNA, Viral ,Viral load ,CCR5 ,DNA - Abstract
The HIV-1 quasispecies in peripheral blood mononuclear cells (PBMC) is considered to be a mix of actively replicating, latent, and archived viruses and may be genetically distinct from HIV-1 variants in plasma that are considered to be recently produced. Here we analyzed the genetic relationship between gp160 env sequences from replication competent clonal HIV-1 variants that were isolated from PBMC and from contemporaneous HIV-1 RNA in serum and HIV-1 proviral DNA in PBMC of four longitudinally studied therapy naive HIV-1 infected individuals. Replication competent clonal HIV-1 variants, HIV-1 RNA from serum, and HIV-1 proviral DNA from PBMC formed a single virus population at most time points analyzed. However, an under-representation in serum of HIV-1 sequences with predicted CXCR4 usage was sometimes observed implying that the analysis of viral sequences from different sources may provide a more complete assessment of the viral quasispecies in peripheral blood in vivo. (C) 2010 Elsevier Inc. All rights reserved
- Published
- 2010
- Full Text
- View/download PDF
14. Absence of HIV‐1 Superinfection 1 Year after Infection between 1985 and 1997 Coincides with a Reduction in Sexual Risk Behavior in the Seroincident Amsterdam Cohort of Homosexual Men
- Author
-
Maria Prins, Andrea Rachinger, Judith A. Burger, Ineke G. Stolte, Angélique B. van 't Wout, Hanneke Schuitemaker, Tom Derks van de Ven, Amsterdam institute for Infection and Immunity, Medical Microbiology and Infection Prevention, Amsterdam Public Health, Infectious diseases, and Experimental Immunology
- Subjects
Male ,Microbiology (medical) ,viruses ,HIV Infections ,Heteroduplex Analysis ,medicine.disease_cause ,Risk-Taking ,Blood serum ,Acquired immunodeficiency syndrome (AIDS) ,medicine ,Cluster Analysis ,Humans ,Homosexuality, Male ,Seroconversion ,Phylogeny ,Netherlands ,business.industry ,Incidence ,Incidence (epidemiology) ,env Gene Products, Human Immunodeficiency Virus ,virus diseases ,Sequence Analysis, DNA ,medicine.disease ,Virology ,Infectious Diseases ,Superinfection ,Cohort ,HIV-1 ,business ,Viral load ,Cohort study - Abstract
Background Incidence rates of human immunodeficiency virus type 1 (HIV-1) superinfection differ among cohorts and, as yet, only 2 cohorts of homosexual men have been screened. Here, we investigated the incidence of HIV-1 superinfection during the first year after infection among homosexual participants in the Amsterdam Cohort Studies on HIV infection and AIDS who seroconverted between 1985 and 1997. Methods We analyzed env C2-C4 diversity in the serum of therapy-naive participants, using a heteroduplex mobility assay; heteroduplexes were considered to be indicators of potential dual infections, in which case env C2-C4 polymerase chain reaction (PCR) products were cloned and sequenced. Sequences were subjected to phylogenetic analysis. Data on the sexual behavior of participants were collected from 1 year before seroconversion until the end of the investigated period. Results For 89 seroconverters with a detectable viral load (>1000 copies/mL), env PCR products were generated from serum samples obtained at seroconversion and 1 year later. Heteroduplexes were observed in 68 of the 89 patients; among these 68 patients, a median of 9 molecular clones per time point was sequenced. Phylogenetic analysis did not reveal evidence for superinfection; 1 patient was HIV-1 coinfected. Shortly after diagnosis of HIV infection, the number of sex partners decreased, the frequency of anal intercourse declined, and condom use increased. Conclusions The incidence of HIV-1 superinfection soon after seroconversion in this cohort is low. Risk reduction shortly after HIV-1 diagnosis early during the HIV-1 epidemic in the Netherlands may have contributed to the absence of HIV-1 superinfection observed in this study.
- Published
- 2010
15. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection
- Author
-
Daniëlle van Manen, Brigitte Boeser-Nunnink, Neeltje A. Kootstra, Muna A. M. Handulle, Hanneke Schuitemaker, Angélique B. van 't Wout, Other departments, AII - Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
Male ,RNA, Untranslated ,Genotype ,Immunology ,Human immunodeficiency virus (HIV) ,HIV Infections ,Single-nucleotide polymorphism ,Genome-wide association study ,HLA-C Antigens ,Biology ,medicine.disease_cause ,Polymorphism, Single Nucleotide ,Immediate-Early Proteins ,Major Histocompatibility Complex ,HLA-C ,medicine ,Humans ,Immunology and Allergy ,Genetic Predisposition to Disease ,Gene ,Genetic association ,Acquired Immunodeficiency Syndrome ,business.industry ,HCP5 ,Clinical course ,Viral Load ,Survival Analysis ,Virology ,CD4 Lymphocyte Count ,Minor allele frequency ,Infectious Diseases ,Disease Progression ,HIV-1 ,RNA, Long Noncoding ,Viral disease ,business ,Viral load ,Follow-Up Studies ,Genome-Wide Association Study - Abstract
Background: Recently, a genome-wide association analysis revealed single-nucleotide polymorphisms (SNPs) in the gene regions of HLA-C and HCP5 to be associated with viral load at set point and SNPs in the RNF39/ZNRD1 gene region to be associated with HIV-1 disease course. Methods: We Studied whether the association of these SNPs with viral load at set point could be replicated and whether these SNPs also associated with other clinical outcomes of HIV-1 infection in 335 HIV-1-infected homosexual participants from the Amsterdam Cohort Studies on HIV infection and AIDS (ACS). Results: Significant associations between the minor allele variants of SNPs HLA-C rs9264942 and HCP5 rs2395029 and a lower viral load at set point could be replicated in the ACS. Moreover, these SNPs were significantly associated with delayed progression to AIDS, AIDS-related death, and a CD4(+) T-cell Count below 400 cells/mu l. Both minor allele variants were independent predictors of disease progression, also when a CCR5 Delta 32 heterozygous genotype was included in the analysis. However, predictive value was not independent from viral load and CD4(+) T-cell count at set point. The SNPs in the RNF39/ZNRD1 gene region were associated with set point CD4(+) T-cell count but riot with disease Course in the ACS. Conclusion: The minor allele variants of SNPs in the HLA-C and HCP5 gene regions are also in the ACS associated with a lower viral load at set point and additionally with delayed HIV-1 disease progression. The association of these SNPs with the relatively early Course of infection may help unravel their mode of action. (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
- Published
- 2009
16. HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study
- Author
-
Lisa P. Jacobson, Benjamin Jacobs, Surafel Gezahegne, James I. Mullins, Joseph B. Margolick, Angélique B. van 't Wout, Geoffrey S. Gottlieb, Kim G. Wong, Laura Heath, Stephanie E Leach, David C. Nickle, Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
Adult ,Male ,Glycosylation ,Time Factors ,Adolescent ,Genotype ,Receptors, CCR5 ,Multicenter AIDS Cohort Study ,Sequence Homology ,HIV Infections ,Article ,Men who have sex with men ,Cohort Studies ,Acquired immunodeficiency syndrome (AIDS) ,medicine ,Immunology and Allergy ,Cluster Analysis ,Humans ,Seroconversion ,Phylogeny ,Polymorphism, Genetic ,biology ,env Gene Products, Human Immunodeficiency Virus ,Homosexuality ,Sequence Analysis, DNA ,Middle Aged ,biology.organism_classification ,medicine.disease ,Virology ,CD4 Lymphocyte Count ,Infectious Diseases ,Cohort ,Lentivirus ,HIV-1 ,RNA, Viral ,Viral disease ,Cohort study - Abstract
Understanding the characteristics of human immunodeficiency virus (HIV) necessary for infection in a new host is a critical goal for acquired immunodeficiency syndrome (AIDS) research. We studied the characteristics of HIV-1 envelope genes in 38 men in the Multicenter AIDS Cohort Study cohort before seroconversion. We found a range of diversity (0.2%-5.6% [median, 0.86%]), V1-V2 loop length (58-93 aa), and potential N-linked glycosylation sites (n = 2-9). However, at least 46% of the men had replicating virus that appeared to have been derived from a single viral variant. Nearly all variants were predicted to be CCR5 tropic. We found no correlation between these viral characteristics and the HIV outcomes of time to clinical AIDS or death and/or a CD4 cell count
- Published
- 2008
17. Isolation and propagation of HIV-1 on peripheral blood mononuclear cells
- Author
-
Neeltje A. Kootstra, Hanneke Schuitemaker, Angélique B. van 't Wout, Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
Virus Cultivation ,HIV Infections ,Viral quasispecies ,Biology ,Virus Replication ,Peripheral blood mononuclear cell ,Virology ,Phenotype ,General Biochemistry, Genetics and Molecular Biology ,Reverse transcriptase ,Virus ,In vitro ,Viral replication ,HIV-1 ,Leukocytes, Mononuclear ,Humans ,Function (biology) - Abstract
Human immunodeficiency virus type 1 (HIV-1) infection is characterized by a gradual loss of CD4+ T cells and T-cell function and an ongoing high level of virus replication. The high replication rate and the error-prone nature of HIV-1 reverse transcriptase create a diverse viral quasispecies throughout infection. To study biological properties of HIV-1 quasispecies in relation to the clinical course of infection, the in vitro preservation of phenotypical characteristics of the virus is essential. Here, we describe the method for bulk isolation of the HIV-1 quasispecies and a limiting dilution virus isolation protocol by which single coexisting HIV-1 variants can be obtained using peripheral blood mononuclear cells from a healthy donor as target cells. In addition, methods for propagation and titration of HIV-1 are provided.
- Published
- 2008
18. DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner
- Author
-
Angélique B. van 't Wout, Karel A. van Dort, Neeltje A. Kootstra, Thijs Booiman, Vladimir V. Loukachov, Other departments, AII - Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
Transcription, Genetic ,viruses ,lcsh:Medicine ,Protein Serine-Threonine Kinases ,Biology ,Virus Replication ,Transcription (biology) ,Humans ,lcsh:Science ,Transcription factor ,HIV Long Terminal Repeat ,Host factor ,Multidisciplinary ,NFATC Transcription Factors ,lcsh:R ,NFAT ,Protein-Tyrosine Kinases ,Provirus ,Molecular biology ,Cell biology ,HEK293 Cells ,Viral replication ,HIV-1 ,lcsh:Q ,Protein Binding ,Research Article - Abstract
Background Transcription of the HIV-1 provirus is regulated by both viral and host proteins and is very important in the context of viral latency. In latently infected cells, viral gene expression is inhibited as a result of the sequestration of host transcription factors and epigenetic modifications. Results In our present study we analyzed the effect of host factor dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) on HIV-1 replication. We show that DYRK1A controls HIV-1 replication by regulating provirus transcription. Downregulation or inhibition of DYRK1A increased LTR-driven transcription and viral replication in cell lines and primary PBMC. Furthermore, inhibition of DYRK1A resulted in reactivation of latent HIV-1 provirus to a similar extent as two commonly used broad-spectrum HDAC inhibitors. We observed that DYRK1A regulates HIV-1 transcription via the Nuclear Factor of Activated T-cells (NFAT) by promoting its translocation from the nucleus to the cytoplasm. Therefore, inhibition of DYRK1A results in increased nuclear levels of NFAT and increased NFAT binding to the viral LTR and thus increasing viral transcription. Conclusions Our data indicate that host factor DYRK1A plays a role in the regulation of viral transcription and latency. Therefore, DYRK1A might be an attractive candidate for therapeutic strategies targeting the viral reservoir.
- Published
- 2015
19. Phosphodiesterase 8a supports HIV-1 replication in macrophages at the level of reverse transcription
- Author
-
Viviana Cobos Jiménez, Karel A. van Dort, Thijs Booiman, Neeltje A. Kootstra, Angélique B. van 't Wout, Other departments, Experimental Immunology, and Amsterdam institute for Infection and Immunity
- Subjects
Cellular differentiation ,Immune Cells ,Immunology ,lcsh:Medicine ,Viral diseases ,Biology ,Virus Replication ,Microbiology ,Virus ,Gene Expression Regulation, Enzymologic ,Monocytes ,White Blood Cells ,Animal Cells ,Virology ,Humans ,lcsh:Science ,Regulation of gene expression ,Medicine and health sciences ,Multidisciplinary ,Blood Cells ,Base Sequence ,Macrophages ,HEK 293 cells ,lcsh:R ,DNA replication ,virus diseases ,Phosphodiesterase ,Biology and Life Sciences ,Cell Differentiation ,Infectious Disease Immunology ,Reverse Transcription ,Cell Biology ,Reverse transcriptase ,Viral Replication ,AIDS ,MicroRNAs ,HEK293 Cells ,Viral replication ,3',5'-Cyclic-AMP Phosphodiesterases ,Gene Knockdown Techniques ,HIV-1 ,Cytokines ,Infectious diseases ,lcsh:Q ,Clinical Immunology ,Cellular Types ,Research Article ,HIV infections - Abstract
BACKGROUND:HIV-1 infected macrophages play a key role in HIV-1 infection. Even during anti-retroviral treatment, macrophages keep producing virus due to suboptimal tissue penetration and reduced efficacy of antiretrovirals. It is therefore of major importance to understand which host factors are involved in HIV-1 replication in macrophages. Previously, we have shown that genetic polymorphisms in phosphodiesterase 8a (PDE8A) are strongly associated with HIV-1 replication in these cells. Here we analyzed the mechanism and regulation of PDE8A in HIV-1 replication in macrophages. RESULTS:PDE8A mRNA expression strongly increases upon differentiation of monocytes into macrophages, which corresponds to the increased susceptibility of mature macrophages to HIV-1. In parallel, expression of microRNA miR-145-5p, predicted to target PDE8A mRNA, strongly decreased. The interaction of miR-145-5p with the 3' UTR of PDE8A mRNA could be experimentally validated, suggesting that indeed miR-145-5p can regulate PDE8A expression levels. Knockdown of PDE8A in macrophages resulted in a decrease in total HIV-1 replication and proviral DNA levels. These observations confirm that PDE8A regulates HIV-1 replication in macrophages and that this effect is mediated through early steps in the viral replication cycle. CONCLUSIONS:PDE8A is highly expressed in macrophages, and its expression is regulated by miR-145-5p. Our findings strongly suggest that PDE8A supports HIV-1 replication in macrophages and that this effect is mediated at the level of reverse transcription.
- Published
- 2014
20. Cytopathicity of Human Immunodeficiency Virus Type 1 Primary Isolates Depends on Coreceptor Usage and Not Patient Disease Status
- Author
-
David Kwa, Hanneke Schuitemaker, Verena Trautner, Ruth I. Connor, Mark A. Goldsmith, Angélique B. van 't Wout, James I. Mullins, Birgit Schramm, Jason F. Kreisberg, and Other departments
- Subjects
CD4-Positive T-Lymphocytes ,Receptors, CXCR4 ,Disease status ,Receptors, CCR5 ,viruses ,Immunology ,Disease progression ,Lymphocyte depletion ,Human immunodeficiency virus (HIV) ,virus diseases ,HIV Infections ,Disease ,Biology ,medicine.disease_cause ,Microbiology ,Virology ,Lymphocyte Depletion ,Cytopathogenic Effect, Viral ,Insect Science ,HIV-1 ,medicine ,Humans ,Pathogenesis and Immunity - Abstract
It has been hypothesized that human immunodeficiency virus type 1 (HIV-1) evolves toward increased cytopathicity in conjunction with disease progression in infected patients. A viral property known to evolve in some but not all patients is coreceptor utilization, and it has been shown that a switch in coreceptor utilization is sufficient for the development of increased cytopathicity. To test the hypothesis that the evolution of other viral properties also contributes to accelerating cytopathicity in vivo, we used human lymphoid tissue explants to assay the cytopathicity of a panel of primary HIV-1 isolates derived from various stages of disease characterized by the presence or absence of changes in coreceptor preference. We found no evidence of coreceptor-independent increases in cytopathicity in isolates obtained either before coreceptor preference changes or from patients who progressed to AIDS despite an absence of coreceptor evolution. Instead, the cytopathicity of all HIV-1 isolates was determined solely by their coreceptor utilization. These results argue that HIV-1 does not evolve toward increased cytopathicity independently of changes in coreceptor utilization.
- Published
- 2001
21. R5 Strains of Human Immunodeficiency Virus Type 1 from Rapid Progressors Lacking X4 Strains Do Not Possess X4-Type Pathogenicity in Human Thymus
- Author
-
Robert D. Berkowitz, Mary E. Moreno, Valerie Linquist-Stepps, Bare Christopher B, Hanneke Schuitemaker, Cheryl A. Stoddart, Neeltje A. Kootstra, Angélique B. van 't Wout, and Joseph M. McCune
- Subjects
viruses ,Immunology ,Human immunodeficiency virus (HIV) ,HIV Infections ,Mice, SCID ,Thymus Gland ,Biology ,medicine.disease_cause ,Microbiology ,Virus ,Mice ,HUMAN THYMUS ,Acquired immunodeficiency syndrome (AIDS) ,Virology ,medicine ,Animals ,Humans ,Host (biology) ,Disease progression ,medicine.disease ,Pathogenicity ,Rapid disease progression ,Disease Models, Animal ,Insect Science ,Disease Progression ,HIV-1 ,Pathogenesis and Immunity - Abstract
Some individuals infected with only R5 strains of human immunodeficiency virus type 1 progress to AIDS as quickly as individuals harboring X4 strains. We determined that three R5 viruses were much less pathogenic than an X4 virus in SCID-hu Thy/Liv mice, suggesting that R5 virus-mediated rapid disease progression is associated with host, not viral, factors.
- Published
- 1999
22. Infectious Cellular Load in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals and Susceptibility of Peripheral Blood Mononuclear Cells from Their Exposed Partners to Non-Syncytium-Inducing HIV-1 as Major Determinants for HIV-1 Transmission in Homosexual Couples
- Author
-
Rene P. M. Keet, Hetty Blaak, Roel A. Coutinho, Angélique B. van 't Wout, Hanneke Schuitemaker, Marion Cornelissen, M. Brouwer, Jaap Goudsmit, Neeltje A. Kootstra, Nel Albrecht-van Lent, and Other departments
- Subjects
Adult ,Male ,Heterozygote ,Genotype ,Receptors, CCR5 ,Immunology ,Viral Pathogenesis and Immunity ,HIV Infections ,Biology ,Microbiology ,Peripheral blood mononuclear cell ,Virus ,Loss of heterozygosity ,Risk-Taking ,Cytopathogenic Effect, Viral ,Risk Factors ,Virology ,Humans ,Homosexuality, Male ,Gene ,DNA Primers ,Sequence Deletion ,Syncytium ,Base Sequence ,Transmission (medicine) ,Genetic Variation ,virus diseases ,Heterozygote advantage ,Middle Aged ,CD4 Lymphocyte Count ,Insect Science ,HIV-1 ,Leukocytes, Mononuclear ,Female - Abstract
To study risk factors for homosexual transmission of human immunodeficiency virus type 1 (HIV-1), we compared 10 monogamous homosexual couples between whom transmission of HIV-1 had occurred with 10 monogamous homosexual couples between whom HIV-1 transmission had not occurred despite high-risk sexual behavior. In the group of individuals who did not transmit virus, peripheral cellular infectious load was lower and the CD4 + T-cell counts were higher than in the group of transmitters. HIV-1 RNA levels in serum did not differ between transmitters and nontransmitters. Compared with peripheral blood mononuclear cells (PBMC) from normal healthy blood donors, 8 of 10 nonrecipients and only 3 of 8 recipients had PBMC with reduced susceptibility to in vitro infection with non-syncytium-inducing (NSI) HIV-1 variants isolated from either their respective partners or an unrelated individual. No difference in susceptibility was observed for infection with a syncytium-inducing variant. Among the individuals who had PBMC with reduced susceptibility, five nonrecipients and one recipient had PBMC that were equally or even less susceptible to NSI variants than PBMC that had low susceptibility and that were derived from healthy blood donors that were heterozygous for a 32-bp deletion in the CCR5 gene (CCR5 Δ32). Three of these individuals (all nonrecipients) had a CCR5 Δ32 heterozygous genotype themselves, confirming an association between low susceptibility to NSI variants and CCR5 Δ32 heterozygosity. All three recipients with less susceptible PBMC had partners with a high infectious cellular load; inversely, both nonrecipients with normally susceptible PBMC had partners with a very low infectious cellular load. These results suggest that a combination of susceptibility of target cells and inoculum size upon homosexual exposure largely determines whether HIV-1 infection is established.
- Published
- 1998
23. HIV-1 envelope diversity 1 year after seroconversion predicts subsequent disease progression
- Author
-
Neeltje A. Kootstra, Andrea Rachinger, Hanneke Schuitemaker, Angélique B. van 't Wout, Tom L.G.M. van den Kerkhof, Esther F. Gijsbers, Amsterdam institute for Infection and Immunity, Experimental Immunology, Other departments, and Medical Microbiology and Infection Prevention
- Subjects
CD4-Positive T-Lymphocytes ,Male ,Time Factors ,Receptors, CCR5 ,Immunology ,HIV Infections ,Human leukocyte antigen ,Heteroduplex Analysis ,Biology ,Immune system ,Acquired immunodeficiency syndrome (AIDS) ,Viral Envelope Proteins ,HLA Antigens ,Genotype ,HIV Seropositivity ,medicine ,Clinical endpoint ,Immunology and Allergy ,Humans ,Prospective Studies ,Seroconversion ,Homosexuality, Male ,Genetic diversity ,Acquired Immunodeficiency Syndrome ,Viral Load ,medicine.disease ,Virology ,Infectious Diseases ,Disease Progression ,HIV-1 ,RNA, Viral ,Viral load ,human activities ,Biomarkers - Abstract
Objective: Recent studies have suggested that the dynamics of HIV-1 evolutionary rate reflect the rate of disease progression. We wished to determine whether viral diversity early in infection is predictive of the subsequent disease course. Design: HIV-1 envelope diversity at seroconversion and 1 year thereafter from 89 homosexual participants of the Amsterdam Cohort Studies on HIV infection and AIDS was correlated with clinical endpoints and markers of disease progression. Methods: Heteroduplex mobility assay (HMA) and sequencing followed by calculation of pairwise genetic distances were applied to determine HIV-1 envelope diversity. The HMA pattern (presence or absence of heteroduplexes) and sequence diversity were each tested for correlation with the clinical course of infection. Results: HMA pattern at 1-year postseroconversion was significantly associated with progression to AIDS and AIDS-related death, with presence of heteroduplexes associated with accelerated disease progression. Moreover, not only this dichotomous measure of viral diversity (absence or presence of heteroduplexes), but also genetic diversity itself was associated with disease course. HMA pattern was an independent predictor of accelerated disease progression, also when CCR5 genotype, human leukocyte antigen (HLA)-type, viral load, CD4(+) T-cell counts, and coreceptor use at viral load set point were included in the analysis. Conclusion: Viral diversity early in HIV-1 infection is predictive of the subsequent disease progression. It remains to be established whether viral diversity itself plays a causal role in the increased damage to the immune system or whether it is a reflection of immune pressure or other selective forces. (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
- Published
- 2012
24. Contributors
- Author
-
Frederick L. Altice, Andrew F. Angelino, Leyla Azis, John G. Bartlett, Robert J. Blount, R. Douglas Bruce, Richard Chaisson, David B. Clifford, Susa Coffey, David A. Cooper, Suzanne M. Crowe, J. Lucian Davis, Kevin M. De Cock, Douglas T. Dieterich, Elizabeth H. Doby, W. Lawrence Drew, James P. Dunn, Jerrold J. Ellner, Kim S. Erlich, Charles W. Flexner, Gerald Friedland, Monica Gandhi, Trevor E. Gerntholtz, Clive M. Gray, Ruth M. Greenblatt, Warner C. Greene, Deborah Greenspan, John S. Greenspan, Carl Grunfeld, Pamela Gumbi, Guan-Zhu Han, Laurence Huang, Jula K. Inrig, Mark A. Jacobson, Malcolm John, Edward C. Jones-López, Salim S. Abdool Karim, Anthony D. Kelleher, Jerome H. Kim, Jeffrey D. Klausner, Paul E. Klotman, Jane E. Koehler, Oliver Laeyendecker, Elysia Larson, Simon Mallal, Toby Maurer, Concepta Merry, Nelson L. Michael, Rakesh K. Mishra, Ronald T. Mitsuyasu, Lynne M. Mofenson, Pablo A. Moncado, Jose G. Montoya, David Nolan, Chiadi U. Onyike, Julie Overbaugh, Kathleen R. Page, Andrew T. Pavia, B. Matija Peterlin, Marion G. Peters, William G. Powderly, Thomas C. Quinn, Mopo Radebe, Peter Reiss, Merle A. Sande, Monika Sarkar, Morris Schambelan, Hanneke Schuitemaker, James C. Shepherd, Thira Sirisanthana, Matthew Stremlau, Khuanchai Supparatpinyo, Lynda A. Szczech, Steven A. Taylor, Mengesha A. Teshome, Glenn J. Treisman, Marie-Louise Vachon, Daniëlle van Manen, Angélique B. van 't Wout, Paul A. Volberding, Mark A. Wainberg, Bruce Walker, Michael Worobey, Gerasimos J. Zaharatos, Irum Zaidi, and Lycias Zembe
- Published
- 2012
25. Reconstructing the Dynamics of HIV Evolution within Hosts from Serial Deep Sequence Data
- Author
-
Diana Edo-Matas, Art F. Y. Poon, Hanneke Schuitemaker, Evelien M. Bunnik, P. Richard Harrigan, Angélique B. van 't Wout, Luke C. Swenson, Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
0106 biological sciences ,Viral Diseases ,HIV Infections ,01 natural sciences ,Genotype ,Biology (General) ,Molecular clock ,Phylogeny ,Genetics ,0303 health sciences ,Ecology ,Phylogenetic tree ,virus diseases ,High-Throughput Nucleotide Sequencing ,3. Good health ,Infectious Diseases ,Phenotype ,Computational Theory and Mathematics ,Modeling and Simulation ,Viral evolution ,Host-Pathogen Interactions ,Medicine ,RNA, Viral ,Sequence Analysis ,Algorithms ,Research Article ,Ancestral reconstruction ,Receptors, CXCR4 ,Receptors, CCR5 ,QH301-705.5 ,Molecular Sequence Data ,Biology ,010603 evolutionary biology ,Evolution, Molecular ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Acquired immunodeficiency syndrome (AIDS) ,Phylogenetics ,Evolutionary Modeling ,medicine ,Humans ,Amino Acid Sequence ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,030304 developmental biology ,Human evolutionary genetics ,Computational Biology ,HIV ,medicine.disease ,Mutation ,HIV-1 ,Genetic Fitness ,Population Genetics - Abstract
At the early stage of infection, human immunodeficiency virus (HIV)-1 predominantly uses the CCR5 coreceptor for host cell entry. The subsequent emergence of HIV variants that use the CXCR4 coreceptor in roughly half of all infections is associated with an accelerated decline of CD4+ T-cells and rate of progression to AIDS. The presence of a ‘fitness valley’ separating CCR5- and CXCR4-using genotypes is postulated to be a biological determinant of whether the HIV coreceptor switch occurs. Using phylogenetic methods to reconstruct the evolutionary dynamics of HIV within hosts enables us to discriminate between competing models of this process. We have developed a phylogenetic pipeline for the molecular clock analysis, ancestral reconstruction, and visualization of deep sequence data. These data were generated by next-generation sequencing of HIV RNA extracted from longitudinal serum samples (median 7 time points) from 8 untreated subjects with chronic HIV infections (Amsterdam Cohort Studies on HIV-1 infection and AIDS). We used the known dates of sampling to directly estimate rates of evolution and to map ancestral mutations to a reconstructed timeline in units of days. HIV coreceptor usage was predicted from reconstructed ancestral sequences using the geno2pheno algorithm. We determined that the first mutations contributing to CXCR4 use emerged about 16 (per subject range 4 to 30) months before the earliest predicted CXCR4-using ancestor, which preceded the first positive cell-based assay of CXCR4 usage by 10 (range 5 to 25) months. CXCR4 usage arose in multiple lineages within 5 of 8 subjects, and ancestral lineages following alternate mutational pathways before going extinct were common. We observed highly patient-specific distributions and time-scales of mutation accumulation, implying that the role of a fitness valley is contingent on the genotype of the transmitted variant., Author Summary At the start of infection, human immunodeficiency virus (HIV) generally requires a specific protein receptor (CCR5) on the cell surface to bind and enter the cell. In roughly half of all HIV infections, the virus population eventually switches to using a different receptor (CXCR4). This ‘HIV coreceptor switch’ is associated with an accelerated rate of progression to AIDS. Although it is not known why this switch occurs in some infections and not others, it is thought to be shaped by constraints on how HIV can evolve from one mode to another. In this study, we test this hypothesis by reconstructing the evolutionary histories of HIV within 8 patients known to have undergone an HIV coreceptor switch. Each history is recreated from samples of HIV genetic sequences that were derived from repeated blood samples by next-generation sequencing, an emerging technology that is rapidly becoming an essential tool in the study of rapidly-evolving populations such as viruses or cancerous cells. Because we have samples from different points in time, we can use models of evolution to extrapolate back in time to the ancestors of each infection. Our analysis reveals patient-specific dynamics in HIV evolution that sheds new light on the determinants of the coreceptor switch.
- Published
- 2012
26. Viral and host determinants of HIV-1 disease progression
- Author
-
Daniëlle van Manen, Hanneke Schuitemaker, and Angélique B. van 't Wout
- Subjects
Host (biology) ,Disease progression ,Human immunodeficiency virus (HIV) ,medicine ,Biology ,medicine.disease_cause ,Virology - Published
- 2012
27. Changing Virus-Host Interactions in the Course of HIV-1 Infection
- Author
-
Peter Th. A. Schellekens, Matthus Tersmette, Angélique B. van 't Wout, Hanneke Schuitemaker, Martlin Groenink, Frank Miedema, M. Koot, Ron A. M. Fouchier, Marijke T. L. Roos, Michèl R. Klein, and L. Meyaard
- Subjects
CD4-Positive T-Lymphocytes ,Acquired Immunodeficiency Syndrome ,Immunity, Cellular ,Virus host ,Immunology ,Human immunodeficiency virus (HIV) ,HIV Infections ,Biology ,medicine.disease ,medicine.disease_cause ,biology.organism_classification ,Virology ,Lymphocyte Depletion ,Virus ,Acquired immunodeficiency syndrome (AIDS) ,Acute Disease ,Disease Progression ,HIV-1 ,medicine ,Humans ,Immunology and Allergy ,Viral disease ,Sida ,Zidovudine - Published
- 1994
28. Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia
- Author
-
Margit Sieberer, Peter Portegies, Angélique B. van 't Wout, Frank de Wolf, Sebastiaan Bol, Brigitte Boeser-Nunnink, Neeltje A. Kootstra, Ard van Sighem, Hanneke Schuitemaker, Evelien M. Bunnik, Daniëlle van Manen, Thijs Booiman, Other departments, Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
Candidate gene ,Viral Diseases ,AIDS Dementia Complex ,Receptors, CCR5 ,lcsh:Medicine ,Single-nucleotide polymorphism ,HIV Infections ,Biology ,Bioinformatics ,Polymorphism, Single Nucleotide ,Genotype ,Genetics ,SNP ,Humans ,Allele ,lcsh:Science ,Gene ,Chemokine CCL2 ,Homeodomain Proteins ,Clinical Genetics ,Multidisciplinary ,Macrophages ,lcsh:R ,Case-control study ,HIV ,Infectious Diseases ,Neurology ,Case-Control Studies ,Medicine ,lcsh:Q ,Viral load ,Population Genetics ,Research Article ,Neuroscience - Abstract
Background Infection with HIV-1 may result in severe cognitive and motor impairment, referred to as HIV-1-associated dementia (HAD). While its prevalence has dropped significantly in the era of combination antiretroviral therapy, milder neurocognitive disorders persist with a high prevalence. To identify additional therapeutic targets for treating HIV-associated neurocognitive disorders, several candidate gene polymorphisms have been evaluated, but few have been replicated across multiple studies. Methods We here tested 7 candidate gene polymorphisms for association with HAD in a case-control study consisting of 86 HAD cases and 246 non-HAD AIDS patients as controls. Since infected monocytes and macrophages are thought to play an important role in the infection of the brain, 5 recently identified single nucleotide polymorphisms (SNPs) affecting HIV-1 replication in macrophages in vitro were also tested. Results The CCR5 wt/Δ32 genotype was only associated with HAD in individuals who developed AIDS prior to 1991, in agreement with the observed fading effect of this genotype on viral load set point. A significant difference in genotype distribution among all cases and controls irrespective of year of AIDS diagnosis was found only for a SNP in candidate gene PREP1 (p = 1.2×10−5). Prep1 has recently been identified as a transcription factor preferentially binding the −2,518 G allele in the promoter of the gene encoding MCP-1, a protein with a well established role in the etiology of HAD. Conclusion These results support previous findings suggesting an important role for MCP-1 in the onset of HIV-1-associated neurocognitive disorders.
- Published
- 2011
29. Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course
- Author
-
Ruben van 't Slot, Aeilko H. Zwinderman, Sophie Limou, Jean-François Zagury, Neeltje A. Kootstra, Daniëlle van Manen, Brigitte Boeser-Nunnink, Angélique B. van 't Wout, Perry D. Moerland, Sebastiaan Bol, Judith A. Burger, Olivier Delaneau, Hanneke Schuitemaker, Other departments, AII - Amsterdam institute for Infection and Immunity, Experimental Immunology, Medical Microbiology and Infection Prevention, APH - Amsterdam Public Health, and Epidemiology and Data Science
- Subjects
Male ,lcsh:Medicine ,Genome-wide association study ,HIV Infections ,Bioinformatics ,Cohort Studies ,lcsh:Science ,Netherlands ,Multidisciplinary ,Genomics ,Middle Aged ,Viral Load ,AIDS ,Cohort ,Disease Progression ,Medicine ,Infectious diseases ,Female ,HIV clinical manifestations ,Cohort study ,Research Article ,Adult ,Infectious Disease Control ,Sexually Transmitted Diseases ,Single-nucleotide polymorphism ,Viral diseases ,Biology ,Polymorphism, Single Nucleotide ,Young Adult ,Acquired immunodeficiency syndrome (AIDS) ,Genome Analysis Tools ,medicine ,Genome-Wide Association Studies ,Genetics ,SNP ,Humans ,Seroconversion ,Survival analysis ,Genetic Association Studies ,Genome, Human ,lcsh:R ,Computational Biology ,HIV ,Human Genetics ,medicine.disease ,Survival Analysis ,Immunology ,HIV-1 ,lcsh:Q ,Genome-Wide Association Study - Abstract
BACKGROUND: AIDS develops typically after 7-11 years of untreated HIV-1 infection, with extremes of very rapid disease progression (15 years). To reveal additional host genetic factors that may impact on the clinical course of HIV-1 infection, we designed a genome-wide association study (GWAS) in 404 participants of the Amsterdam Cohort Studies on HIV-1 infection and AIDS. METHODS: The association of SNP genotypes with the clinical course of HIV-1 infection was tested in Cox regression survival analyses using AIDS-diagnosis and AIDS-related death as endpoints. RESULTS: Multiple, not previously identified SNPs, were identified to be strongly associated with disease progression after HIV-1 infection, albeit not genome-wide significant. However, three independent SNPs in the top ten associations between SNP genotypes and time between seroconversion and AIDS-diagnosis, and one from the top ten associations between SNP genotypes and time between seroconversion and AIDS-related death, had P-values smaller than 0.05 in the French Genomics of Resistance to Immunodeficiency Virus cohort on disease progression. CONCLUSIONS: Our study emphasizes that the use of different phenotypes in GWAS may be useful to unravel the full spectrum of host genetic factors that may be associated with the clinical course of HIV-1 infection.
- Published
- 2011
30. Low Incidence of HIV-1 Superinfection Even After Episodes of Unsafe Sexual Behavior of Homosexual Men in the Amsterdam Cohort Studies on HIV Infection and AIDS
- Author
-
Ineke G. Stolte, Maria Prins, Andrea Rachinger, Judith A. Burger, Tom Derks van de Ven, Angélique B. van 't Wout, Precious Manyenga, Hanneke Schuitemaker, Amsterdam institute for Infection and Immunity, Medical Microbiology and Infection Prevention, Amsterdam Public Health, Infectious diseases, and Experimental Immunology
- Subjects
Male ,Maximum likelihood ,viruses ,Human immunodeficiency virus (HIV) ,HIV Infections ,Biology ,medicine.disease_cause ,Genes, env ,Risk-Taking ,Acquired immunodeficiency syndrome (AIDS) ,medicine ,Immunology and Allergy ,Humans ,Prospective Studies ,Homosexuality, Male ,Phylogeny ,Netherlands ,Unsafe Sex ,Incidence (epidemiology) ,virus diseases ,Serum samples ,medicine.disease ,Genes, gag ,Infectious Diseases ,Sexual behavior ,Superinfection ,Immunology ,HIV-1 ,RNA, Viral ,Cohort study - Abstract
Background. Human immunodeficiency virus type 1 (HIV-1) superinfection is infection of an HIV-1 seropositive individual with another HIV-1 strain. The rate at which HIV-1 superinfection occurs might be influenced by sexual behavior. Superinfection might be detected more often by analyzing longitudinal samples collected from time periods of unsafe sexual behavior. Methods. Envelope C2-C4 and gag sequences were generated from HIV-1 RNA from longitudinal serum samples that were obtained around self-reported sexual risk periods from 15 homosexual therapy-naive men who participated in the Amsterdam Cohort Studies on HIV Infection and AIDS. Maximum likelihood phylogenetic analysis was used to determine whether HIV-1 superinfection had occurred. Results. We studied a total of 124 serum samples from 15 patients with a median of 8 samples and of 5.8 person-years of follow-up per patient. Phylogenetic analysis on 907 C2-C4 env and 672 gag sequences revealed no case of HIV-1 superinfection, resulting in a superinfection incidence rate of 0 per 100 person-years [95% CI: 0 - -4.2]. Conclusions. We conclude that HIV-1 superinfection incidence is low in this subgroup of homosexual men who reported unsafe sexual behavior. Additional studies are required to estimate the impact of also other factors, which may determine the risk to acquire HIV-1 superinfection
- Published
- 2011
31. Genome-Wide Association Study Identifies Single Nucleotide Polymorphism in DYRK1A Associated with Replication of HIV-1 in Monocyte-Derived Macrophages
- Author
-
Perry D. Moerland, Jean-François Zagury, Cédric Coulonges, Margit Sieberer, Daniëlle van Manen, Jeremy J. Martinson, Sophie Limou, Jacques Fellay, Ruben van 't Slot, Hanneke Schuitemaker, Joshua T. Herbeck, Jantine G. Sietzema, Yvonne van Remmerden, Sebastiaan Bol, Angélique B. van 't Wout, Faculteit der Geneeskunde, Landsteiner Laboratory, Sanquin Research, Department of Experimental Immunology, Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA)-University of Amsterdam [Amsterdam] (UvA)-Center for Infection and Immunity Amsterdam (CINIMA), Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, University of Amsterdam [Amsterdam] (UvA)-University of Amsterdam [Amsterdam] (UvA), Netherlands Bioinformatics Center (NBIC), Netherlands Bioinformatics Center, Chaire de Bioinformatique, Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Department of Microbiology, University of Washington School of Medicine, Center for Human Genome Variation, Duke University [Durham], Complex Genetics Section, Department of Biomedical Genetics, University Medical Center [Utrecht], Department of Human Genetics, University of Pittsburgh (PITT), Pennsylvania Commonwealth System of Higher Education (PCSHE)-Pennsylvania Commonwealth System of Higher Education (PCSHE), The authors acknowledge funding from the Landsteiner Foundation Blood Research (registration number 0526) and the European Union (Marie Curie International Reintegration Grant 029167). The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute. UO1-AI-35042, UL1-RR025005 (GCRC), UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041., Guellaen, Georges, University of Amsterdam [Amsterdam] (UvA)-Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA)-Center for Infection and Immunity Amsterdam (CINIMA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10, Amsterdam institute for Infection and Immunity, Amsterdam Public Health, Epidemiology and Data Science, Other departments, and Experimental Immunology
- Subjects
Male ,lcsh:Medicine ,HIV Infections ,Genome-wide association study ,Virus Replication ,Linkage Disequilibrium ,Monocytes ,0302 clinical medicine ,MESH: Animals ,lcsh:Science ,Cells, Cultured ,0303 health sciences ,Multidisciplinary ,MESH: Enzyme-Linked Immunosorbent Assay ,MESH: Feces ,Genomics ,Middle Aged ,Protein-Tyrosine Kinases ,3. Good health ,SNP genotyping ,Host-Pathogen Interaction ,MESH: Entamoebiasis ,Medicine ,Infectious diseases ,Female ,Research Article ,Adult ,medicine.medical_specialty ,Immune Cells ,Immunology ,Retrovirology and HIV immunopathogenesis ,Single-nucleotide polymorphism ,Viral diseases ,Protein Serine-Threonine Kinases ,Biology ,Polymorphism, Single Nucleotide ,Microbiology ,Virus ,03 medical and health sciences ,Genome Analysis Tools ,In vivo ,Virology ,Molecular genetics ,Genome-Wide Association Studies ,Genetics ,[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,medicine ,Humans ,MESH: Antibodies, Protozoan ,Genetic Predisposition to Disease ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,030304 developmental biology ,Macrophages ,Host Cells ,lcsh:R ,DNA replication ,Computational Biology ,HIV ,Human Genetics ,MESH: Entamoeba histolytica ,MESH: Liver Abscess, Amebic ,Viral Replication ,Viral replication ,HIV-1 ,Clinical Immunology ,lcsh:Q ,Viral Transmission and Infection ,030217 neurology & neurosurgery ,Genome-Wide Association Study ,MESH: Antigens, Protozoan - Abstract
International audience; Background: HIV-1 infected macrophages play an important role in rendering resting T cells permissive for infection, in spreading HIV-1 to T cells, and in the pathogenesis of AIDS dementia. During highly active anti-retroviral treatment (HAART), macrophages keep producing virus because tissue penetration of antiretrovirals is suboptimal and the efficacy of some is reduced. Thus, to cure HIV-1 infection with antiretrovirals we will also need to efficiently inhibit viral replication in macrophages. The majority of the current drugs block the action of viral enzymes, whereas there is an abundance of yet unidentified host factors that could be targeted. We here present results from a genome-wide association study identifying novel genetic polymorphisms that affect in vitro HIV-1 replication in macrophages. Methodology/Principal Findings: Monocyte-derived macrophages from 393 blood donors were infected with HIV-1 and viral replication was determined using Gag p24 antigen levels. Genomic DNA from individuals with macrophages that had relatively low (n = 96) or high (n = 96) p24 production was used for SNP genotyping with the Illumina 610 Quad beadchip. A total of 494,656 SNPs that passed quality control were tested for association with HIV-1 replication in macrophages, using linear regression. We found a strong association between in vitro HIV-1 replication in monocyte-derived macrophages and SNP rs12483205 in DYRK1A (p = 2.1661025). While the association was not genome-wide significant (p,161027), we could replicate this association using monocyte-derived macrophages from an independent group of 31 individuals (p = 0.0034). Combined analysis of the initial and replication cohort increased the strength of the association (p = 4.8461026). In addition, we found this SNP to be associated with HIV-1 disease progression in vivo in two independent cohort studies (p = 0.035 and p = 0.0048). Conclusions/Significance: These findings suggest that the kinase DYRK1A is involved in the replication of HIV-1, in vitro in macrophages as well as in vivo.
- Published
- 2011
32. Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing
- Author
-
Angélique B. van 't Wout, Arne Frantzell, Christos J. Petropoulos, Eoin Coakley, Winnie Dong, Evelien M. Bunnik, P. Richard Harrigan, Hanneke Schuitemaker, Diana Edo-Matas, Wei Huang, Luke C. Swenson, Faculteit der Geneeskunde, AII - Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
lcsh:Immunologic diseases. Allergy ,Receptors, CXCR4 ,Viral Diseases ,Time Factors ,Receptors, CCR5 ,Sequence analysis ,Immunology ,HIV Infections ,V3 loop ,Biology ,Microbiology ,CXCR4 ,Viral Evolution ,03 medical and health sciences ,Immunodeficiency Viruses ,Viral envelope ,Virology ,Genetic variation ,Genetics ,Humans ,lcsh:QH301-705.5 ,Molecular Biology ,030304 developmental biology ,0303 health sciences ,Transition (genetics) ,Sequence Analysis, RNA ,030306 microbiology ,env Gene Products, Human Immunodeficiency Virus ,Genetic Variation ,Computational Biology ,HIV ,RNA ,virus diseases ,Biological Evolution ,Phenotype ,3. Good health ,Infectious Diseases ,lcsh:Biology (General) ,HIV-1 ,RNA, Viral ,Medicine ,Parasitology ,lcsh:RC581-607 ,Sequence Analysis ,Research Article - Abstract
The emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants is associated with accelerated disease progression. CXCR4-using variants are believed to evolve from CCR5-using variants, but due to the extremely low frequency at which transitional intermediate variants are often present, the kinetics and mutational pathways involved in this process have been difficult to study and are therefore poorly understood. Here, we used ultra-deep sequencing of the V3 loop of the viral envelope in combination with the V3-based coreceptor prediction tools PSSMNSI/SI and geno2pheno[coreceptor] to detect HIV-1 variants during the transition from CCR5- to CXCR4-usage. We analyzed PBMC and serum samples obtained from eight HIV-1-infected individuals at three-month intervals up to one year prior to the first phenotypic detection of CXCR4-using variants in the MT-2 assay. Between 3,482 and 10,521 reads were generated from each sample. In all individuals, V3 sequences of predicted CXCR4-using HIV-1 were detected at least three months prior to phenotypic detection of CXCR4-using variants in the MT-2 assay. Subsequent analysis of the genetic relationships of these V3 sequences using minimum spanning trees revealed that the transition in coreceptor usage followed a stepwise mutational pathway involving sequential intermediate variants, which were generally present at relatively low frequencies compared to the major predicted CCR5- and CXCR4-using variants. In addition, we observed differences between individuals with respect to the number of predicted CXCR4-using variants, the diversity among major predicted CCR5-using variants, and the presence or absence of intermediate variants with discordant phenotype predictions. These results provide the first detailed description of the mutational pathways in V3 during the transition from CCR5- to CXCR4-usage in natural HIV-1 infection., Author Summary The first step in the infection of a target cell by human immunodeficiency virus type 1 (HIV-1) is binding of the envelope spike to its receptor CD4 and a coreceptor on the cellular surface. HIV-1 variants present early in the course of infection mainly use the coreceptor CCR5, while virus variants that use CXCR4 can appear later in infection. This change in coreceptor usage is associated with mutations in the third variable (V3) loop of the envelope spike, but has been difficult to study due to the low presence of intermediate variants. Using ultra-deep sequencing, we obtained thousands of sequences of the V3 loop from HIV-1 infected individuals in the year before CXCR4-using variants were first detected, including sequences from almost all intermediate variants. We show that mutations are introduced sequentially in the V3 loop during the evolution from CCR5- to CXCR4-usage. Furthermore, we describe differences and similarities between HIV-1-infected individuals that are related to this change in coreceptor usage, which provides the first detailed overview of this evolutionary process during natural HIV-1 infection.
- Published
- 2011
33. Evaluation of pre-screening methods for the identification of HIV-1 superinfection
- Author
-
Tom Derks van de Ven, Angélique B. van 't Wout, Hanneke Schuitemaker, Andrea Rachinger, Judith A. Burger, Amsterdam institute for Infection and Immunity, Medical Microbiology and Infection Prevention, and Experimental Immunology
- Subjects
Male ,Sequence analysis ,Population ,Electrophoretic Mobility Shift Assay ,HIV Infections ,Heteroduplex Analysis ,Biology ,medicine.disease_cause ,Polymerase Chain Reaction ,Sensitivity and Specificity ,law.invention ,law ,Virology ,medicine ,Humans ,Seroconversion ,Homosexuality, Male ,education ,Polymerase chain reaction ,Genetics ,Genetic diversity ,education.field_of_study ,env Gene Products, Human Immunodeficiency Virus ,Genetic distance ,Superinfection ,HIV-1 ,Heteroduplex - Abstract
The aim of this study was to compare sensitivity thresholds of two pre-screening methods - the heteroduplex mobility assay (HMA) and the presence of ambiguity codes in population-based sequences - applied for detection of HIV-1 superinfection. HIV-1 env C2-C4 PCR products generated from 48 serum samples isolated from 24 HIV-1 positive and therapy-nave homosexual men at seroconversion and at approximately 1 year thereafter were subjected to HMA and population sequencing. Clonal sequence analysis was used to determine the sensitivity of each method to detect sequence variability. Results from HMA were compared to pairwise genetic distance of clonal sequences; heteroduplexes resulted from as little as 1.4% pairwise distance between two sequences and were detected even when only 1.5% of the pairwise distance comparisons exceeded this distance threshold. By contrast, the ambiguity code approach using population-based sequencing detected only 20.1% of existing sequence variation and was less sensitive to minority populations
- Published
- 2009
34. Comparison of Human Immunodeficiency Virus Type 1 Tropism Profiles in Clinical Samples by the Trofile and MT-2 Assays▿
- Author
-
Wei Huang, Eoin Coakley, Yolanda Lie, Soumi Gupta, Irma Maurer, Agnes M. Harskamp, Christos J. Petropoulos, Marga Mangas-Ruiz, Jacqueline D. Reeves, Angélique B. van 't Wout, Hanneke Schuitemaker, Other departments, Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
Pharmacology ,Receptors, CXCR4 ,CCR5 receptor antagonist ,Biology ,biology.organism_classification ,Virology ,Antiviral Agents ,Virus ,Plasma ,Viral Tropism ,Infectious Diseases ,Lentivirus ,Immunology ,Tissue tropism ,HIV-1 ,Leukocytes, Mononuclear ,Humans ,Pharmacology (medical) ,Viral disease ,Seroconversion ,Tropism ,Trofile assay - Abstract
The recent availability of CCR5 antagonists as anti-human immunodeficiency virus (anti-HIV) therapeutics has highlighted the need to accurately identify CXCR4-using variants in patient samples when use of this new drug class is considered. The Trofile assay (Monogram Biosciences) has become the method that is the most widely used to define tropism in the clinic prior to the use of a CCR5 antagonist. By comparison, the MT-2 assay has been used since early in the HIV epidemic to define tropism in clinical specimens. Given that there are few data from direct comparisons of these two assays, we evaluated the performance of the plasma-based Trofile assay and the peripheral blood mononuclear cell (PBMC)-based MT-2 assay for the detection of CXCR4 use in defining the tropism of HIV isolates derived from clinical samples. The various samples used for this comparison were derived from participants of the Amsterdam Cohort Studies on HIV infection and AIDS who underwent consecutive MT-2 assay testing of their PBMCs at approximately 3-month intervals. This unique sample set was specifically selected because consecutive MT-2 assays had demonstrated a shift from negative to positive in PBMCs, reflecting the first emergence of CXCR4-using virus in PBMCs above the level of detection of the assay in these individuals. Trofile testing was performed with clonal HIV type 1 (HIV-1) variants (n= 21), MT-2 cell culture-derived cells (n= 20) and supernatants (n= 42), and plasma samples (n= 76). Among the clonal HIV-1 variants and MT-2 cell culture-derived samples, the results of the Trofile and MT-2 assays demonstrated a high degree of concordance (95% to 98%). Among consecutive plasma samples, detection of CXCR4-using virus was at or before the time of first detection by the MT-2 assay in 5/10 patients by the original Trofile assay and in 9/10 patients by the enhanced-sensitivity Trofile assay. Differences in the time to the first detection of CXCR4 use between the MT-2 assay (PBMCs) and the original Trofile assay (plasma) were greatly reduced by the enhanced-sensitivity Trofile assay, suggesting that sensitivity for the detection of minor CXCR4-using variants may be a more important determinant of discordant findings than compartmentalization. The similarities in performance of the enhanced-sensitivity Trofile and MT-2 assays suggest that either may be an appropriate methodology to define tropism in patient specimens.
- Published
- 2009
35. Evidence for limited genetic compartmentalization of HIV-1 between lung and blood
- Author
-
Laura Heath, Angélique B. van 't Wout, Jan McClure, Hong Zhao, Homer L. Twigg, John E. Mittler, Alan Fox, Jeffrey T. Schouten, David R. Park, Kurt Diem, Lawrence Corey, James I. Mullins, Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
Glycosylation ,T-Lymphocytes ,lcsh:Medicine ,HIV Infections ,Bronchoalveolar Lavage ,Polymerase Chain Reaction ,law.invention ,0302 clinical medicine ,law ,Genotype ,Blood plasma ,030212 general & internal medicine ,lcsh:Science ,Lung ,Polymerase chain reaction ,Phylogeny ,0303 health sciences ,Multidisciplinary ,medicine.diagnostic_test ,Compartmentalization (psychology) ,Infectious Diseases/HIV Infection and AIDS ,respiratory system ,Computational Biology/Evolutionary Modeling ,Virology/Virus Evolution and Symbiosis ,3. Good health ,medicine.anatomical_structure ,Evolutionary Biology/Microbial Evolution and Genomics ,Virology/Immunodeficiency Viruses ,Research Article ,Biology ,Peripheral blood mononuclear cell ,03 medical and health sciences ,Immune system ,Infectious Diseases/Viral Infections ,medicine ,Humans ,030304 developmental biology ,Models, Statistical ,Infectious Diseases/Respiratory Infections ,lcsh:R ,Virology/Persistence and Latency ,Genetic Variation ,Sequence Analysis, DNA ,Virology ,respiratory tract diseases ,Bronchoalveolar lavage ,Immunology ,HIV-1 ,Leukocytes, Mononuclear ,RNA ,lcsh:Q - Abstract
Background HIV-1 is frequently detected in the lungs of infected individuals and is likely important in the development of pulmonary opportunistic infections. The unique environment of the lung, rich in alveolar macrophages and with specialized local immune responses, may contribute to differential evolution or selection of HIV-1. Methodology and Findings We characterized HIV-1 in the lung in relation to contemporaneous viral populations in the blood. The C2-V5 region of HIV-1 env was sequenced from paired lung (induced sputum or bronchoalveolar lavage) and blood (plasma RNA and proviral DNA from sorted or unsorted PBMC) from 18 subjects. Compartmentalization between tissue pairs was assessed using 5 established tree or distance-based methods, including permutation tests to determine statistical significance. We found statistical evidence of compartmentalization between lung and blood in 10/18 subjects, although lung and blood sequences were intermingled on phylogenetic trees in all subjects. The subject showing the greatest compartmentalization contained many nearly identical sequences in BAL sample, suggesting clonal expansion may contribute to reduced viral diversity in the lung in some cases. However, HIV-1 sequences in lung were not more homogeneous overall, nor were we able to find a lung-specific genotype associated with macrophage tropism in V3. In all four subjects in whom predicted X4 genotypes were found in blood, predicted X4 genotypes were also found in lung. Conclusions Our results support a picture of continuous migration of HIV-1 between circulating blood and lung tissue, with perhaps a very limited degree of localized evolution or clonal replication.
- Published
- 2009
36. Blood monocytes harbor HIV type 1 strains with diversified phenotypes including macrophage-specific CCR5 virus
- Author
-
Carrie K. Wilcox, Tuofu Zhu, Nicholas Llewellyn, Younong Xu, Haiying Zhu, Leonidas Stamatatos, James I. Mullins, Angélique B. van 't Wout, Lawrence Corey, Thomas Andrus, Amsterdam institute for Infection and Immunity, and Experimental Immunology
- Subjects
Adult ,CD4-Positive T-Lymphocytes ,Male ,Receptors, CCR5 ,viruses ,HIV Infections ,Biology ,HIV Envelope Protein gp120 ,CXCR4 ,Virus ,Monocytes ,medicine ,Immunology and Allergy ,Macrophage ,Humans ,Amino Acid Sequence ,Seroconversion ,Tropism ,Monocyte ,Macrophages ,virus diseases ,Middle Aged ,biology.organism_classification ,Phenotype ,Virology ,Peptide Fragments ,Infectious Diseases ,medicine.anatomical_structure ,Lentivirus ,HIV-1 ,Female ,Sequence Alignment - Abstract
Background. Recent studies have shown that blood monocytes harbor human immunodeficiency virus type 1 (HIV-1) variants that are genotypically distinguishable from those in CD4 + T cells. However, the biological function of monocyte-derived HIV-1 remains unclear. Methods. Using pseudovirus assay, we analyzed the phenotype conferred by monocyte-derived HIV-1 envelopes from 8 patients. Results. All pseudoviruses carrying monocyte-derived HIV-1 envelopes used CCR5; however, their use of additional coreceptors delineated 4 phenotypes in which viruses used (1) CCR5 only, (2) CCR5 and CXCR4, (3) CCR3 and CCR5, or (4) multiple coreceptors, including CCR1, CCR3, GPR15, CCR5, and CXCR4. More importantly, we observed 2 distinct cell tropism phenotypes for pseudoviruses carrying monocyte-derived envelopes: (1) monocyte-derived, macrophage-specific R5 (MDMS-R5) virus that, using CCR5 only, could infect monocyte-derived macrophages (MDMs) but not CD4 + T cells and (2) dual tropic virus that infected both MDMs and primary CD4 + T cells. We found blood monocytes harboring viruses with multiple phenotypes as early as 25 days before seroconversion and as late as 9 years after seroconversion. Conclusions. These data suggest that HIV-1 circulating in blood monocytes represents diverse HIV-1 with multiple phenotypes and that MDMS-R5 viruses may play an important role in infection with and persistence of HIV-1 within the monocyte/macrophage lineage.
- Published
- 2008
37. Viral and Host Determinants of HIV-1 Disease Progression
- Author
-
Angélique B. van 't Wout and Hanneke Schuitemaker
- Subjects
Host (biology) ,Disease progression ,Human immunodeficiency virus (HIV) ,medicine ,Biology ,medicine.disease_cause ,Virology - Published
- 2008
38. T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates
- Author
-
Floris P. J. van Alphen, Angélique B. van 't Wout, Ad C. van Nuenen, Hanneke Schuitemaker, Esther D. Quakkelaar, Tim Beaumont, Brigitte Boeser-Nunnink, Other departments, Experimental Immunology, Amsterdam institute for Infection and Immunity, and Medical Microbiology and Infection Prevention
- Subjects
T cell ,T-Lymphocytes ,Molecular Sequence Data ,Human immunodeficiency virus (HIV) ,Envelope glycoprotein ,Viral quasispecies ,HIV Antibodies ,medicine.disease_cause ,Peripheral blood mononuclear cell ,Neutralization ,Cell Line ,Proviruses ,Neutralization Tests ,Virology ,medicine ,Humans ,Amino Acid Sequence ,Selection, Genetic ,De novo mutations ,Phylogeny ,biology ,T cell line ,Base Sequence ,Genetic Variation ,Adaptation, Physiological ,medicine.anatomical_structure ,Mutation ,biology.protein ,HIV-1 ,RNA, Viral ,Antibody ,Adaptation ,Sequence Alignment - Abstract
Primary human immunodeficiency type 1 viruses (HIV-1) resist antibody neutralization but become sensitive after passage through T cell lines. We and others previously reported an increased neutralization sensitivity of HIV-1 after prolonged culture on primary peripheral blood mononuclear cells (PBMC). Hence we hypothesized that adaptation to growth in T cell lines is in fact selection of a pre-existing neutralization-sensitive HIV-1 variant from the quasispecies in the PBMC culture. Indeed, increased neutralization sensitivity was associated with largely identical synonymous and non-synonymous mutations between progeny of parallel H9 passages from the same split inoculum from 2 of 3 viruses. H9 T cell line adaptation of molecular cloned HIV-1 was less successful and associated with only a few de novo mutations that varied between parallel H9-adapted progeny from the same split inoculum. We conclude that T cell line adaptation of HIV-1 can indeed select for a pre-existing variant but that this most likely depends on the viral diversity in the inoculum.
- Published
- 2006
39. A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences
- Author
-
James I. Mullins, Angélique B. van 't Wout, Mark A. Jensen, Mia Coetzer, Lynn Morris, and Experimental Immunology
- Subjects
Genetics ,biology ,Sequence analysis ,Immunology ,Reproducibility of Results ,Sequence Analysis, DNA ,V3 loop ,HIV Envelope Protein gp120 ,biology.organism_classification ,Microbiology ,Phenotype ,Confidence interval ,Virus ,Peptide Fragments ,Genetic Diversity and Evolution ,Predictive Value of Tests ,Virology ,Insect Science ,Lentivirus ,Genotype ,HIV-1 ,Humans ,Viral disease - Abstract
In human immunodeficiency virus type 1 (HIV-1) subtype B infections, the emergence of viruses able to use CXCR4 as a coreceptor is well documented and associated with accelerated CD4 decline and disease progression. However, in HIV-1 subtype C infections, responsible for more than 50% of global infections, CXCR4 usage is less common, even in individuals with advanced disease. A reliable phenotype prediction method based on genetic sequence analysis could provide a rapid and less expensive approach to identify possible CXCR4 variants and thus increase our understanding of subtype C coreceptor usage. For subtype B V3 loop sequences, genotypic predictors have been developed based on position-specific scoring matrices (PSSM). In this study, we apply this methodology to a training set of 279 subtype C sequences of known phenotypes (228 non-syncytium-inducing [NSI] CCR5 + and 51 SI CXCR4 + sequences) to derive a C-PSSM predictor. Specificity and sensitivity distributions were estimated by combining data set bootstrapping with leave-one-out cross-validation, with random sampling of single sequences from individuals on each bootstrap iteration. The C-PSSM had an estimated specificity of 94% (confidence interval [CI], 92% to 96%) and a sensitivity of 75% (CI, 68% to 82%), which is significantly more sensitive than predictions based on other methods, including a commonly used method based on the presence of positively charged residues (sensitivity, 47.8%). A specificity of 83% and a sensitivity of 83% were achieved with a validation set of 24 SI and 47 NSI unique subtype C sequences. The C-PSSM performs as well on subtype C V3 loops as existing subtype B-specific methods do on subtype B V3 loops. We present bioinformatic evidence that particular sites may influence coreceptor usage differently, depending on the subtype.
- Published
- 2006
40. Gene expression profiling of HIV-1 infection using cDNA microarrays
- Author
-
Angélique B, van 't Wout
- Subjects
CD4-Positive T-Lymphocytes ,Jurkat Cells ,Spectrometry, Fluorescence ,Gene Expression Profiling ,HIV-1 ,Humans ,HIV Infections ,Cell Line ,Oligonucleotide Array Sequence Analysis - Abstract
To illustrate the methods employed in gene expression profiling using cDNA microarrays, infection of CD4+ T cell lines with HIV-1LAI is used to identify expression changes relevant to in vitro HIV-1 infection. Cell lines are infected at a high multiplicity of infection to ensure a population of near-synchronously infected cells to be compared to uninfected cells. Infection status is verified using flow cytometry to determine the intracellular expression of the viral gag p24 protein before samples are harvested for total RNA extraction. Total RNA is extracted and amplified using commercially available kits, and RNA quality is verified using Bioanalyzer technology. To obtain fluorescently labeled cDNA probes, the amplified RNA is reverse-transcribed to yield cDNA, using random nonamers in the presence of dye-labeled dCTP. After first-strand cDNA synthesis, RNA is degraded and the probes are purified. For each infection condition (LAI and mock), two slides are hybridized with identical probes generated from the same RNAs, but with fluorescent labels reversed on one of the slides to control for dye-specific effects. Troubleshooting strategies and issues to consider prior to starting the experiment are discussed in detail in the notes section.
- Published
- 2005
41. Gene Expression Profiling of HIV-1 Infection Using cDNA Microarrays
- Author
-
Angélique B. van 't Wout
- Subjects
education.field_of_study ,medicine.diagnostic_test ,Population ,RNA ,Biology ,Molecular biology ,In vitro ,Flow cytometry ,Gene expression profiling ,Multiplicity of infection ,Cell culture ,Complementary DNA ,medicine ,education - Abstract
To illustrate the methods employed in gene expression profiling using cDNA microarrays, infection of CD4+ T cell lines with HIV-1LAI is used to identify expression changes relevant to in vitro HIV-1 infection. Cell lines are infected at a high multiplicity of infection to ensure a population of near-synchronously infected cells to be compared to uninfected cells. Infection status is verified using flow cytometry to determine the intracellular expression of the viral gag p24 protein before samples are harvested for total RNA extraction. Total RNA is extracted and amplified using commercially available kits, and RNA quality is verified using Bioanalyzer technology. To obtain fluorescently labeled cDNA probes, the amplified RNA is reverse-transcribed to yield cDNA, using random nonamers in the presence of dye-labeled dCTP. After first-strand cDNA synthesis, RNA is degraded and the probes are purified. For each infection condition (LAI and mock), two slides are hybridized with identical probes generated from the same RNAs, but with fluorescent labels reversed on one of the slides to control for dye-specific effects. Troubleshooting strategies and issues to consider prior to starting the experiment are discussed in detail in the notes section.
- Published
- 2005
42. Lower Limits of Detection for Single Biological Particles Using Impedance Spectroscopy
- Author
-
John E. Mittler, Ashutosh Shastry, Pahnit Seriburi, Shih-hui Chao, Deirdre R. Meldrum, Angélique B. van 't Wout, and John H. Koschwanez
- Subjects
Detection limit ,Materials science ,business.industry ,Biological particles ,Analytical chemistry ,Optoelectronics ,business ,Dielectric spectroscopy - Abstract
Single-cell impedance spectroscopy integrated with lab-on-a-chip systems provides a direct and minimally invasive approach for monitoring and characterizing properties of individual cells in real-time. Here we investigate the theoretical potential and limitations of this technique for analyzing single membrane-bound particles as small as 100 nm in diameter. Our theoretical model suggests a lower limit of detection for single cells on the order of a few microns.Copyright © 2005 by ASME
- Published
- 2005
43. Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells
- Author
-
Ushnal Rao, Michael Schindler, Frank Kirchhoff, Angélique B. van 't Wout, J. Victor Swain, James I. Mullins, Melissa S. Pathmajeyan, and Experimental Immunology
- Subjects
T-Lymphocytes ,Immunology ,HIV Infections ,Biology ,Microbiology ,Jurkat cells ,Virus ,Cell Line ,Jurkat Cells ,chemistry.chemical_compound ,Virology ,Aspartic Acid Endopeptidases ,Humans ,Gene ,Oligonucleotide Array Sequence Analysis ,Microarray analysis techniques ,Cholesterol ,Gene Expression Profiling ,virus diseases ,Molecular biology ,Virus-Cell Interactions ,Gene expression profiling ,Viral replication ,chemistry ,Cell culture ,Insect Science ,HIV-1 - Abstract
Several recent reports indicate that cholesterol might play an important role in human immunodeficiency virus type 1 (HIV-1) replication. We investigated the effects of HIV-1 infection on cholesterol biosynthesis and uptake using microarrays. HIV-1 increased gene expression of cholesterol genes in both transformed T-cell lines and primary CD4 + T cells. Consistent with our microarray data, 14 C-labeled mevalonate and acetate incorporation was increased in HIV-1-infected cells. Our data also demonstrate that changes in cholesterol biosynthesis and uptake are only observed in the presence of functional Nef, suggesting that increased cholesterol synthesis may contribute to Nef-mediated enhancement of virion infectivity and viral replication.
- Published
- 2005
44. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences
- Author
-
Mark A. Jensen, James I. Mullins, Daniel Shriner, Sherry McLaughlin, Hong Xia He, Angélique B. van 't Wout, David C. Nickle, Fu Sheng Li, Raj Shankarappa, Joseph B. Margolick, and Experimental Immunology
- Subjects
Receptors, CXCR4 ,Genotype ,Receptors, CCR5 ,viruses ,Immunology ,Mutant ,Molecular Sequence Data ,HIV Infections ,Biology ,V3 loop ,HIV Envelope Protein gp120 ,Microbiology ,Virus ,Evolution, Molecular ,Viral entry ,Predictive Value of Tests ,Virology ,Genetic variation ,Humans ,Phylogeny ,Genetics ,Computational Biology ,Sequence Analysis, DNA ,Phenotype ,Peptide Fragments ,Insect Science ,GenBank ,HIV-1 ,Recombination and Evolution - Abstract
Early studies of the biological properties of human immunodeficiency virus type 1 (HIV-1) found that virus isolates could be placed into as few as two phenotypic categories (defined in vitro as either non-syncytium-inducing [NSI] or syncytium-inducing [SI]) in certain CD4+ T-cell lines. These phenotypes were often found to be associated with differences in growth properties and cytopathicity on peripheral blood mononuclear cells (PBMC) (1, 14, 46) and in cellular host range (3, 48). Ultimately, the difference between the NSI and SI phenotypes was shown to be due largely to the differential use of chemokine receptors as coreceptors for viral entry: NSI viruses predominantly use CCR5, while SI viruses can use CCR5 and CXCR4 or CXCR4 exclusively (2, 29, 31, 52, 54). Results determined on the basis of SI phenotype and/or coreceptor usage typing showed that although HIV-1 present at primary infections used the CCR5 coreceptor (R5 virus) ∼90% of the time (63, 67, 68), a substantial proportion of individuals eventually developed virus that used the CXCR4 coreceptor (X4 virus). These X4/SI viruses are associated with accelerated CD4 decline and more rapid progression of HIV-1 disease (8, 28, 33, 43, 47). Little is known about the mechanisms by which these viruses come to predominate among the HIV-1 strains present in an infected person. For example, it is not known whether X4 emergence is a primary pathogenic event or is secondary to some other event, i.e., whether the virus itself causes accelerated disease progression or whether another event causes the acceleration and perhaps also leads to X4 outgrowth. Another important unanswered question is whether X4 viruses arise multiple times during the course of disease and, if so, why they do not become dominant whenever they emerge. There is also uncertainty about the frequency with which phenotype transition occurs. Phenotypic studies suggest that 50 to 60% of progressing subjects acquire X4/SI virus (26, 57, 58), but the results of a detailed longitudinal genotypic study have indicated the occurrence, sometimes transient, of at least one of four X4-associated mutations in nine of nine individuals (50). Coreceptor usage of a particular virus is established by functional assays (growth on MT2 cells [28] or infection of indicator cell lines [64]). These assays are limited, however, in that results are generally reported only as positive or negative and provide no insight into the sequence of mutations responsible for the phenotype switch—information which may further clarify the role of X4 viruses in pathogenesis, as we discuss below. Certain mutations, particularly in the V3 loop of env (5-7, 15, 16, 22, 23, 51), are strongly associated with syncytium induction and CXCR4 usage; in particular, basic amino acids at V3 positions 11 and 25 (amino acid coordinates 306 and 322 [GenBank accession no. {"type":"entrez-nucleotide","attrs":{"text":"K03455","term_id":"1906382","term_text":"K03455"}}K03455] in standard reference HXB2) very frequently distinguish primary X4 from R5 viruses (9, 15, 16, 21, 42, 66), with positions 24 and 27 implicated in some cases (10, 37). However, while evolutionary studies of the R5-X4 transition have been undertaken (30, 38, 61, 62), the actual mutational pathway or pathways by which R5 viruses that establish infections in vivo evolve into X4 viruses (i.e., the specific evolutionary sequence of mutations required) has been largely unexplored. It is not clear whether the appearance of basic amino acids at sites 11 and 25 is sufficient or even necessary in most cases in vivo to lead to the outgrowth of X4 virus or whether, instead, a more gradual process of mutation accumulation takes place. If mutant accumulation does occur in a more gradual process, this may provide an opportunity for both early detection and arrest of X4 development. Viruses that can use both coreceptors (R5X4 viruses) are known to arise around the time of R5-to-X4 transition (2, 8, 38, 61), but their evolutionary role in that transition is not certain. The answers to questions of in vivo evolution cannot be approached by phenotypic assays alone, and analyses based on the appearance of positively charged mutations at V3 sites 11 and 25 have led to incomplete and sometimes ambiguous conclusions regarding the transition process (35). The V3 loop is highly variable within and between individuals, and bioinformatic approaches suggest that many changes not yet examined virologically are likely to influence coreceptor usage (21, 24, 42). To gain a broader understanding of the mutations that contribute to X4 phenotype and of the temporal sequence in which they occur, we used position-specific scoring matrices (PSSM) (19, 20) to analyze V3 sequences. PSSM are used to detect nonrandom distributions of amino acids at adjacent sites associated with empirically determined groupings of sequences. They are frequently used to search DNA or protein sequences for particular motifs, e.g., transcriptional regulatory sites (55), coiled-coil domains (32), major histocompatibility complex class I binding sites (41), and others. A PSSM uses background genetic variation as a baseline comparison, or “null model,” to facilitate comparison of the residues of a sequence fragment to those of a group of aligned sequences known to have the desired property. The comparison leads to a score that can be interpreted as indicating the likelihood that the sequence fragment has the property of interest. In our study, the empirical groupings consist of V3 loop sequences associated with X4 (or SI) virus and R5 (or NSI) viruses. Using the PSSM as described below, a sequence can be assigned a score: the higher the score, the more closely the sequence resembles those of known X4 viruses. We used the PSSM score for two purposes. First, we developed a PSSM-based phenotype predictor usable for all V3 sequences. We explored the statistical properties of this predictor and showed that it outperforms simple methods that categorize sequences on the basis of the presence of basic amino acids at sites 11 or 25. We validated the predictor with two sets of V3 sequences from phenotyped viruses different from those used to produce the PSSM matrix. Second, we showed that the score can serve as a measure of the transition from R5 to X4 phenotype. Since the PSSM score can act as a continuous indicator of X4 evolution, we used it to identify common temporal patterns among 11 serially sampled individuals. By scoring reconstructed ancestors of the sampled virus for each subject, we demonstrated that the progression from low-scoring (R5-like) to high-scoring (X4-like) viruses was generally gradual but that the loss of putative X4 virus at the later stages of infection can occur in two different ways.
- Published
- 2003
45. Predicting HIV-1 coreceptor usage with sequence analysis
- Author
-
Mark A, Jensen and Angélique B, van 't Wout
- Subjects
Phenotype ,Receptors, HIV ,Genotype ,HIV-1 ,Computational Biology ,Humans ,HIV Infections - Abstract
Bioinformatics approaches are increasingly being used to identify and understand the genetic variation underlying changes in HIV-1 biological phenotype. The variable regions of the viral envelope are the major determinant of virus coreceptor usage and cell tropism. Specifically, amino acids 11 and 25 in the 3rd variable (V3) loop have been found to strongly influence viral syncytium inducing capacity and coreceptor usage. Many additional V3 loop changes, however, as well as changes elsewhere in Env, are thought to contribute to phenotype. In this review we describe several recently developed methods to analyze this variability and their use to predict biological phenotype based on sequence information. These approaches have identified changes in the V3 loop, in addition to the known changes at positions 11 and 25, that affect phenotype and significantly enhance our ability to predict phenotype from genotype. Besides improving phenotype prediction, methods that score V3 sequences on a continuous scale can also assist in the interpretation of evolutionary information about shifts in phenotype, and the relationship between that evolution and pathogenesis. Several examples and potential practical applications of this scoring are discussed. We conclude that advances in computational approaches have enhanced both our ability to predict and to understand HIV-1 biological phenotype evolution. Further development of these methods, by extending analysis to regions outside the V3 loop and to clades beyond subtype B, will extend our understanding of HIV-1 pathogenesis and inform treatment strategies.
- Published
- 2003
46. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines
- Author
-
Gary K. Geiss, Svetlana A. Mikheeva, James I. Mullins, Ginger K. Lehrman, Angélique B. van 't Wout, Gemma C. O'Keeffe, Roger E. Bumgarner, Michael G. Katze, and Experimental Immunology
- Subjects
CD4-Positive T-Lymphocytes ,Gene Expression Regulation, Viral ,Immunology ,Biology ,Microbiology ,Cell Line ,Interferon ,Virology ,Gene expression ,medicine ,Gene ,Transcription factor ,DNA Primers ,Regulation of gene expression ,Base Sequence ,Microarray analysis techniques ,Reverse Transcriptase Polymerase Chain Reaction ,Gene Expression Profiling ,Flow Cytometry ,Molecular biology ,Virus-Cell Interactions ,Gene expression profiling ,Insect Science ,HIV-1 ,Cell activation ,medicine.drug - Abstract
The expression levels of ∼4,600 cellular RNA transcripts were assessed in CD4+-T-cell lines at different times after infection with human immunodeficiency virus type 1 strain BRU (HIV-1BRU) using DNA microarrays. We found that several classes of genes were inhibited by HIV-1BRUinfection, consistent with the G2arrest of HIV-1-infected cells induced by Vpr. These included genes involved in cell division and transcription, a family of DEAD-box proteins (RNA helicases), and all genes involved in translation and splicing. However, the overall level of cell activation and signaling was increased in infected cells, consistent with strong virus production. These included a subgroup of transcription factors, including EGR1 and JUN, suggesting they play a specific role in the HIV-1 life cycle. Some regulatory changes were cell line specific; however, the majority, including enzymes involved in cholesterol biosynthesis, of changes were regulated in most infected cell lines. Compendium analysis comparing gene expression profiles of our HIV-1 infection experiments to those of cells exposed to heat shock, interferon, or influenza A virus indicated that HIV-1 infection largely induced specific changes rather than simply activating stress response or cytokine response pathways. Thus, microarray analysis confirmed several known HIV-1 host cell interactions and permitted identification of specific cellular pathways not previously implicated in HIV-1 infection. Continuing analyses are expected to suggest strategies for impacting HIV-1 replication in vivo by targeting these pathways.
- Published
- 2003
47. Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice
- Author
-
Angélique B. van 't Wout, David Camerini, James T. Patrie, Hanneke Schuitemaker, Robert M. Scoggins, James R. Taylor, and Other departments
- Subjects
Receptors, CCR5 ,Immunology ,Cell ,CD4-CD8 Ratio ,Clone (cell biology) ,HIV Infections ,Mice, SCID ,Thymus Gland ,Viral quasispecies ,Biology ,Virus Replication ,Microbiology ,Peripheral blood mononuclear cell ,Pathogenesis ,Mice ,Cytopathogenic Effect, Viral ,Virology ,medicine ,Animals ,Humans ,Homozygote ,Thymocyte ,medicine.anatomical_structure ,Liver ,Viral replication ,Insect Science ,HIV-1 ,Pathogenesis and Immunity - Abstract
We studied the replication and cytopathicity in SCID-hu mice of R5 human immunodeficiency virus type 1 (HIV-1) biological clones from early and late stages of infection of three patients who never developed MT-2 cell syncytium-inducing (SI; R5X4 or X4) viruses. Several of the late-stage non-MT-2 cell syncytium-inducing (NSI; R5) viruses from these patients depleted human CD4+thymocytes from SCID-hu mice. Earlier clones from the same patients did not deplete CD4+thymocytes from SCID-hu mice as well as later clones. We studied three R5 HIV-1 clones from patient ACH142 in greater detail. Two of these clones were obtained prior to the onset of AIDS; the third was obtained following the AIDS diagnosis. In GHOST cell infection assays, all three ACH142 R5 HIV-1 clones could infect GHOST cells expressing CCR5 but not GHOST cells expressing any of nine other HIV coreceptors tested. Furthermore, these patient clones efficiently infected stimulated peripheral blood mononuclear cells from a normal donor but not those from a homozygous CCR5Δ32 individual. Statistical analyses of data obtained from infection of SCID-hu mice with patient ACH142 R5 clones revealed that only the AIDS-associated clone significantly depleted CD4+thymocytes from SCID-hu mice. This clone also replicated to higher levels in SCID-hu mice than the two earlier clones, and a significant correlation between viral replication and CD4+thymocyte depletion was observed. Our results indicate that an intrinsic property of AIDS-associated R5 patient clones causes their increased replication and cytopathic effects in SCID-hu mice and likely contributes to the development of AIDS in patients who harbor only R5 quasispecies of HIV-1.
- Published
- 2000
48. Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs
- Author
-
Stephen Lory, Jeffrey K. Ichikawa, Angélique B. van 't Wout, Gita Bangera, Gary K. Geiss, Roger E. Bumgarner, Anne Norris, and Other departments
- Subjects
Lipopolysaccharides ,Biology ,medicine.disease_cause ,Bacterial Adhesion ,Interferon-gamma ,Gene expression ,medicine ,Tumor Cells, Cultured ,Humans ,RNA, Messenger ,Oligonucleotide Array Sequence Analysis ,Regulation of gene expression ,Multidisciplinary ,Microarray analysis techniques ,Pseudomonas aeruginosa ,Reverse Transcriptase Polymerase Chain Reaction ,Gene Expression Profiling ,Epithelial Cells ,Biological Sciences ,Phosphoproteins ,Molecular biology ,Up-Regulation ,Gene expression profiling ,Bacterial adhesin ,DNA-Binding Proteins ,Gene Expression Regulation ,Genes ,Gene chip analysis ,DNA microarray ,Interferon Regulatory Factor-1 - Abstract
Pseudomonas aeruginosa is an opportunistic pathogen that plays a major role in lung function deterioration in cystic fibrosis patients. To identify critical host responses during infection, we have used high-density DNA microarrays, consisting of 1,506 human cDNA clones, to monitor gene expression in the A549 lung pneumocyte cell line during exposure to P. aeruginosa . We have identified host genes that are differentially expressed upon infection, several of which require interaction with P. aeruginosa and the expression of the major subunit of type IV pili, PilA. Differential expression of genes involved in various cellular functions was identified, and we selected the gene encoding the transcription factor interferon regulatory factor 1 (IRF-1) for further analysis. The levels of the IRF-1 transcript increased 3- to 4-fold in A549 cells after adherence by P. aeruginosa . A similar increase of IRF-1 mRNA was observed in A549 cells exposed to wild-type P. aeruginosa when compared to an isogenic, nonpiliated strain. However, this difference was abolished when serum was present during the incubation of bacteria. Exposure of A549 cells to purified P. aeruginosa lipopolysaccharide did not result in a significant increase in IRF-1 mRNA. Although the P. aeruginosa -induced increased IRF-1 expression depends on the presence of bacterial adhesin, our findings do not preclude the possibility that other bacterial products are responsible for IRF-1 activation, which is enhanced by bacterial adherence to cells. These data show that microarray technology can be an important tool for studying the complex interplay between bacterial pathogens and host.
- Published
- 2000
49. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline
- Author
-
Hanneke Schuitemaker, Egbert Hovenkamp, Angélique B. van 't Wout, Hetty Blaak, Berend Hooibrink, M.H.J. Brouwer, and Other departments
- Subjects
CD4-Positive T-Lymphocytes ,Male ,Receptors, CXCR4 ,Receptors, CCR5 ,T cell ,Cell ,Biology ,Giant Cells ,CXCR4 ,Pathogenesis ,Cytopathogenic Effect, Viral ,T-Lymphocyte Subsets ,In vivo ,immune system diseases ,medicine ,Humans ,Tropism ,Protein Tyrosine Phosphatase, Non-Receptor Type 1 ,Syncytium ,Multidisciplinary ,Genetic Variation ,virus diseases ,Biological Sciences ,biochemical phenomena, metabolism, and nutrition ,Virology ,CD4 Lymphocyte Count ,medicine.anatomical_structure ,Giant cell ,HIV-1 ,Leukocyte Common Antigens - Abstract
Switch from non-syncytium-inducing (NSI) to syncytium-inducing (SI) HIV type 1 (HIV-1) is associated with accelerated CD4+T cell depletion, which might partially be explained by higher virulence of SI variants compared with NSI variants. Because NSI and SI variants use different coreceptors for entry of target cells, altered tropism might offer an explanation for increased pathogenesis associated with SI HIV-1 infection. To investigate whether SI and NSI HIV-1 variants infect different CD4+T cell subsetsin vivo, the distribution of SI and NSI variants over CD4+memory (CD45RA−RO+) and naive (CD45RA+RO−) cells was studied by using limiting dilution cultures. In contrast to NSI variants that were mainly present in CD45RO+cells, SI variants were equally distributed over CD45RO+and CD45RA+cells. Infection of memory cells by both NSI and SI HIV-1 and infection of naive cells primarily by SI HIV-1 corresponded closely with the differential cell surface expression of CXCR4 and CCR5. The frequency of SI-infected CD45RA+CD4+T cells, but not the frequency of NSI- or SI-infected CD45RO+CD4+T cells, correlated with the rate of CD4+T cell depletion. Infection of naive cells by SI HIV-1 may interfere with CD4+T cell production and thus account for rapid CD4+T cell depletion.
- Published
- 2000
50. The Presence of CXCR4-Using HIV-1 Prior to Start of Antiretroviral Therapy Is an Independent Predictor of Delayed Viral Suppression
- Author
-
Ard van Sighem, Kees Brinkman, Hanneke Schuitemaker, Angélique B. van 't Wout, Jan M. Prins, Neeltje A. Kootstra, Matthijs R.A. Welkers, Agnes M. Harskamp, Esther F. Gijsbers, Frank de Wolf, Other departments, Graduate School, Amsterdam institute for Infection and Immunity, Infectious diseases, and Experimental Immunology
- Subjects
Adult ,CD4-Positive T-Lymphocytes ,Male ,Cart ,Receptors, CXCR4 ,Genotype ,T cell ,Population ,lcsh:Medicine ,HIV Infections ,Biology ,CXCR4 ,Cell Line ,Receptors, HIV ,Antiretroviral Therapy, Highly Active ,medicine ,Humans ,lcsh:Science ,education ,education.field_of_study ,Multidisciplinary ,lcsh:R ,virus diseases ,Viral Load ,Prognosis ,Virology ,Antiretroviral therapy ,CD4 Lymphocyte Count ,Treatment Outcome ,medicine.anatomical_structure ,Cell culture ,Immunology ,HIV-1 ,lcsh:Q ,Female ,Viral load ,Research Article - Abstract
The emergence of CXCR4-using HIV variants (X4-HIV) is associated with accelerated disease progression in the absence of antiretroviral therapy. However, the effect of X4-HIV variants on the treatment response remains unclear. Here we determined whether the presence of X4-HIV variants influenced the time to undetectable viral load and CD4+ T cell reconstitution after initiation of cART in 732 patients. The presence of X4-HIV variants was determined by MT-2 assay prior to cART initiation and viral load and CD4+ T cell counts were analyzed every 3 to 6 months during a three year follow-up period. Kaplan-Meier and Cox proportional hazard analyses were performed to compare time to viral suppression and the absolute CD4+ T cell counts and increases in CD4+ T cell counts during follow-up were compared for patients with and without X4-HIV at start of cART. Patients harboring X4-HIV variants at baseline showed a delay in time to achieve viral suppression below the viral load detection limit. This delay in viral suppression was independently associated with high viral load and the presence of X4-HIV variants. Furthermore, the absolute CD4+ T cell counts were significantly lower in patients harboring X4-HIV variants at all time points during follow-up. However, no differences were observed in the increase in absolute CD4+ T cell numbers after treatment initiation, indicating that the reconstitution of CD4+ T cells is independent of the presence of X4-HIV variants. The emergence of X4-HIV has been associated with an accelerated CD4+ T cell decline during the natural course of infection and therefore, patients who develop X4-HIV variants may benefit from earlier treatment initiation in order to obtain faster reconstitution of the CD4+ T cell population to normal levels.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.